{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_core_sci_md-0.2.0.tar.gz\n",
      "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_core_sci_md-0.2.0.tar.gz (91.4 MB)\n",
      "\u001b[K     |████████████████████████████████| 91.4 MB 52.3 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.1.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en-core-sci-md==0.2.0) (2.2.2)\n",
      "Requirement already satisfied: srsly<1.1.0,>=0.1.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (2.0.3)\n",
      "Requirement already satisfied: thinc<7.4.0,>=7.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (7.3.1)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (0.4.1)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (2.24.0)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (0.8.0)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (1.19.2)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (3.0.2)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (1.1.3)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-core-sci-md==0.2.0) (49.2.0.post20200714)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.10.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from thinc<7.4.0,>=7.3.0->spacy>=2.1.3->en-core-sci-md==0.2.0) (4.47.0)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-core-sci-md==0.2.0) (2.10)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-core-sci-md==0.2.0) (3.0.4)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-core-sci-md==0.2.0) (1.25.9)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-core-sci-md==0.2.0) (2020.6.20)\n",
      "Building wheels for collected packages: en-core-sci-md\n",
      "  Building wheel for en-core-sci-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-core-sci-md: filename=en_core_sci_md-0.2.0-py3-none-any.whl size=91566689 sha256=22ebdc58aa7cd57fb92c9a5f356e8988cf283fe85c9d53ff5dd5d05f40000de5\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/c8/51/87/024fd0ff6220b1e8eeeb36979ab7fe73346f239159bd21b919\n",
      "Successfully built en-core-sci-md\n",
      "Installing collected packages: en-core-sci-md\n",
      "Successfully installed en-core-sci-md-0.2.0\n"
     ]
    }
   ],
   "source": [
    "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_core_sci_md-0.2.0.tar.gz                      \n",
    "#install a model for unnamed entity mentions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bc5cdr_md-0.2.0.tar.gz\n",
      "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bc5cdr_md-0.2.0.tar.gz (82.0 MB)\n",
      "\u001b[K     |████████████████████████████████| 82.0 MB 4.7 MB/s eta 0:00:011\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.1.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en-ner-bc5cdr-md==0.2.0) (2.2.2)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (2.24.0)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (0.4.1)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (2.0.3)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (1.19.2)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (3.0.2)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (1.1.3)\n",
      "Requirement already satisfied: thinc<7.4.0,>=7.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (7.3.1)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (49.2.0.post20200714)\n",
      "Requirement already satisfied: srsly<1.1.0,>=0.1.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (0.8.0)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (2020.6.20)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (2.10)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (1.25.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (3.0.4)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.10.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from thinc<7.4.0,>=7.3.0->spacy>=2.1.3->en-ner-bc5cdr-md==0.2.0) (4.47.0)\n",
      "Building wheels for collected packages: en-ner-bc5cdr-md\n",
      "  Building wheel for en-ner-bc5cdr-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-ner-bc5cdr-md: filename=en_ner_bc5cdr_md-0.2.0-py3-none-any.whl size=82155211 sha256=4ed7456ebc52ab144c3922830757e4ee4e903d8347a0b0f0b1d98af6f74ef3dd\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/ff/f5/e6/2c95c0789d5d85cd4c5195865d32ca9a1c246ee86c4c1dd61a\n",
      "Successfully built en-ner-bc5cdr-md\n",
      "Installing collected packages: en-ner-bc5cdr-md\n",
      "Successfully installed en-ner-bc5cdr-md-0.2.0\n"
     ]
    }
   ],
   "source": [
    "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bc5cdr_md-0.2.0.tar.gz                   \n",
    "#install an NER model trained on bc5cdr corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bionlp13cg_md-0.2.0.tar.gz\n",
      "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bionlp13cg_md-0.2.0.tar.gz (82.0 MB)\n",
      "\u001b[K     |████████████████████████████████| 82.0 MB 555 kB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.1.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en-ner-bionlp13cg-md==0.2.0) (2.2.2)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (49.2.0.post20200714)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (3.0.2)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (1.19.2)\n",
      "Requirement already satisfied: srsly<1.1.0,>=0.1.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (1.1.3)\n",
      "Requirement already satisfied: thinc<7.4.0,>=7.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (7.3.1)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (0.8.0)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (0.4.1)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (2.0.3)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (2.24.0)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.10.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from thinc<7.4.0,>=7.3.0->spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (4.47.0)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (3.0.4)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (2020.6.20)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (2.10)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-bionlp13cg-md==0.2.0) (1.25.9)\n",
      "Building wheels for collected packages: en-ner-bionlp13cg-md\n",
      "  Building wheel for en-ner-bionlp13cg-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-ner-bionlp13cg-md: filename=en_ner_bionlp13cg_md-0.2.0-py3-none-any.whl size=82160569 sha256=5424f3b9978990d83666eaaa3a3d8869db2d2225a3dcf832e885d3c90d3d9ac3\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/76/f2/17/95f913580ae6baa325d58c7b1e660957c4577ba55276bd9358\n",
      "Successfully built en-ner-bionlp13cg-md\n",
      "Installing collected packages: en-ner-bionlp13cg-md\n",
      "Successfully installed en-ner-bionlp13cg-md-0.2.0\n"
     ]
    }
   ],
   "source": [
    "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_bionlp13cg_md-0.2.0.tar.gz                \n",
    "#install an NER model trained on bionlp13c corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "import scispacy\n",
    "import spacy\n",
    "from spacy import displacy\n",
    "from collections import Counter\n",
    "#import en_core_web_sm\n",
    "import en_ner_bc5cdr_md\n",
    "#import en_core_sci_sm\n",
    "import en_core_sci_md\n",
    "import en_ner_bionlp13cg_md\n",
    "from scispacy.abbreviation import AbbreviationDetector\n",
    "from scispacy.umls_linking import UmlsEntityLinker\n",
    "from collections import OrderedDict\n",
    "from pprint import pprint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_doc = \"\"\"abstract\n",
    "The prevalence of diabetes is rapidly rising all over the globe at an alarming rate. Over the last three decades, the status of diabetes has been changed, earlier it was considered as a mild disorder of the elderly people. Now it becomes a major cause of morbidity and mortality affecting the youth and middle aged people. According to the Diabetes Atlas 2006 published by the International Diabetes Federation, the number of people with diabetes in India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. The main force of the epidemic of diabetes is the rapid epidemiological transition associated with changes in dietary patterns and decreased physical activity as evident from the higher prevalence of diabetes in the urban population. The most disturbing trend is the shift in age of onset of diabetes to a younger age in the recent years. This could have long lasting adverse effects on nation’s health and economy. Therefore, it is necessary to identify the diabetic patients at the earliest and provide appropriate lifestyle intervention in preventing or postponing the onset of diabetes. In the present review, detailed mechanism and management of the diabetes have been emphasized.\n",
    "\n",
    "\n",
    "Key words\n",
    "Diabetes; prevalence; Diabetic acidosis; pathophysiology.\n",
    "INTRODUCTION\n",
    "Diabetes mellitus is not a single disorder, it represents a series of metabolic conditions associated with hyperglycaemia and caused by defects in insulin secretion and/or insulin action. Exposure to chronic hyperglycaemia may result in microvascular complications in the retina, kidney or periphera.\n",
    "Mechanism\n",
    "Diabetes mellitus (DM) is a set of related diseases in which the body cannot regulate the amount of sugar (specifically, glucose) in the blood.\n",
    "The blood delivers glucose to provide the body with energy to perform all of a person's daily activities. The liver converts the food a person eats into glucose. The glucose is then released into the bloodstream. In a healthy person, the blood glucose level is regulated by several hormones, primarily insulin. Insulin is produced by the pancreas, a small organ between the stomach and liver. The pancreas also makes other important enzymes released directly into the gut that helps digest food. Insulin allows glucose to move out of the blood into cells throughout the body where it is used for fuel. People suffered diabetes either do not produce enough insulin (type 1 diabetes) or cannot use insulin properly (type 2 diabetes), or both (which occurs with several forms of diabetes). In diabetes, glucose in the blood cannot move efficiently into cells, so blood glucose levels remain high. This not only starves all the cells that need the glucose for fuel, but also harms certain organs and tissues exposed to the high glucose levels.\n",
    "TYPES OF DIABETES\n",
    "There are two main types of diabetes type 1 and type 2 with their clinical relevance shown in Table 1 and another type of diabetes is gestational diabetes mellitus.\n",
    "Type 1 diabetes\n",
    "Type 1 diabetes is an autoimmune disease in which the β-cells of the pancreas do not produce sufficient insulin, a hormone which helps use blood sugar (glucose) for energy. The cells become starved of energy and there will be excess of glucose in the blood. This is then followed by life threatening conditions of hypoglycemia, low blood sugar, and hyperglycemia, high blood sugar. When hypoglycemia develops, cells do not get enough glucose and patients suffer of confusion, loss of consciousness, and coma. Even death can results when the brain is deprived of glucose for too long.\n",
    "Hyperglycemia and prolonged absence of insulin may lead to ketoacidosis, which is accumulation of ketones in the blood when the body uses fat for energy instead of glucose. This is because fatty acids cannot be converted into glucose at steady state. Ketones make the blood acidic and slow down all body functions. This also leads to a coma and eventually death [1-6].\n",
    "Type 2 diabetes\n",
    "Type 2 diabetes mellitus is a complex endocrine and metabolic disorder. The interaction between several genetic and environmental factors results in a heterogeneous and progressive disorder with variable degrees of insulin resistance and pancreatic β-cell dysfunction. Overweight and obesity are major contributors to the development of insulin resistance and impaired glucose tolerance. When β cells have not longer able to secrete sufficient insulin to overcome insulin resistance, impaired glucose tolerance progresses to type-2 diabetes. Abnormalities in other hormones such as reduced secretion of the incretin glucagon-like peptide 1 (GLP-1), hyperglucagonaemia, and raised concentrations of other counter-regulatory hormones also contribute to insulin resistance, reduced insulin secretion, and hyper glycaemia in type 2 diabetes[7-13]. Overweight and obesity contribute to insulin resistance through several pathways, including an imbalance in the concentrations of hormones (eg, increased leptin, reduced adiponectin, and increased glucagon), increased concentrations of cytokines (eg, tumour necrosis factor α, interleukin 6), suppressors of cytokine signalling (eg, suppressor of cytokine signalling), other inflammatory signals, and possibly retinol-binding protein 4.1[14-17], Concurrent alterations in β-cell function often include a period of compensatory hyperinsulinaemia with abnormal secretory dynamics. When insulin secretion is no longer sufficient to overcome insulin resistance, glucose intolerance progresses to type 2 diabetes. The decline in β-cell function seems to involve chronic hyperglycaemia (glucotoxicity), chronic exposure to non-esterifies fatty acids (lipotoxicity), oxidative stress, inflammation, and amyloid formation[18–20] Patients with type 2 diabetes usually have pancreatic α-cell dysfunction that results in increased (or nonsuppressed) glucagon secretion in the presence of hyperglycaemia and probably reduced prandial GLP- 1 secretion[21]\n",
    "Gestational diabetes\n",
    "Gestational diabetes mellitus (GDM) is defined as any abnormal carbohydrate intolerance that begins or is first recognized during pregnancy[22]. It does not exclude the possibility that unidentified glucose intolerance have preceded the pregnant state. GDM complicates approximately 7% of pregnancy, which accounts for more than 2,00,000 cases per year[23]. A recent study from India by Seshiah et al. reported the incidence of GDM as 18.9%[24]. The clinical importance of GDM lies in the fact that it is associated with significant maternal and fetal morbidity. In the present review we discuss about the pathophysiology, screening, diagnosis, complications and various management issues pertaining to GDM.\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "def display_entities(model,document):\n",
    "    \"\"\" \n",
    "    This function displays word entities\n",
    "\n",
    "    Parameters: \n",
    "         model(module): A pretrained model from spaCy(https://spacy.io/models) or ScispaCy(https://allenai.github.io/scispacy/)\n",
    "         document(str): Document to be processed\n",
    "\n",
    "    Returns: Image rendering and list of named/unnamed word entities and entity labels \n",
    "     \"\"\"\n",
    "    nlp = model.load()\n",
    "    doc = nlp(document)\n",
    "    displacy_image = displacy.render(doc, jupyter=True,style='ent')\n",
    "    entity_and_label = pprint(set([(X.text, X.label_) for X in doc.ents]))\n",
    "    return  displacy_image, entity_and_label"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[2K\u001b[38;5;2m✔ Loaded compatibility table\u001b[0m\n",
      "\u001b[1m\n",
      "====================== Installed models (spaCy v2.2.2) ======================\u001b[0m\n",
      "\u001b[38;5;4mℹ spaCy installation:\n",
      "/Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages/spacy\u001b[0m\n",
      "\n",
      "TYPE      NAME             MODEL            VERSION                            \n",
      "package   en-core-web-sm   en_core_web_sm   \u001b[38;5;2m2.2.5\u001b[0m   \u001b[38;5;2m✔\u001b[0m\n",
      "package   en-core-web-md   en_core_web_md   \u001b[38;5;2m2.2.5\u001b[0m   \u001b[38;5;2m✔\u001b[0m\n",
      "\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy validate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting en_core_web_md==2.2.5\n",
      "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_md-2.2.5/en_core_web_md-2.2.5.tar.gz (96.4 MB)\n",
      "\u001b[K     |████████████████████████████████| 96.4 MB 2.5 MB/s eta 0:00:011\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.2.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en_core_web_md==2.2.5) (2.2.2)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (49.2.0.post20200714)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (1.1.3)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (1.19.2)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (0.4.1)\n",
      "Requirement already satisfied: srsly<1.1.0,>=0.1.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (1.0.2)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (2.0.3)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (2.24.0)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (0.8.0)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (1.0.2)\n",
      "Requirement already satisfied: thinc<7.4.0,>=7.3.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (7.3.1)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.2.2->en_core_web_md==2.2.5) (3.0.2)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.2->en_core_web_md==2.2.5) (1.25.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.2->en_core_web_md==2.2.5) (3.0.4)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.2->en_core_web_md==2.2.5) (2.10)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.2->en_core_web_md==2.2.5) (2020.6.20)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.10.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from thinc<7.4.0,>=7.3.0->spacy>=2.2.2->en_core_web_md==2.2.5) (4.47.0)\n",
      "Building wheels for collected packages: en-core-web-md\n",
      "  Building wheel for en-core-web-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-core-web-md: filename=en_core_web_md-2.2.5-py3-none-any.whl size=98051302 sha256=ddfaa5dcb20d47ca20a5e2912cff5f90784046ef420ffca8b0e84c36fc90dfeb\n",
      "  Stored in directory: /private/var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/pip-ephem-wheel-cache-jm29616c/wheels/2a/7a/ea/578d59ce717ca06783f1f7b58fadbfd73aab023b6ab1478819\n",
      "Successfully built en-core-web-md\n",
      "Installing collected packages: en-core-web-md\n",
      "  Attempting uninstall: en-core-web-md\n",
      "    Found existing installation: en-core-web-md 2.3.1\n",
      "    Uninstalling en-core-web-md-2.3.1:\n",
      "      Successfully uninstalled en-core-web-md-2.3.1\n",
      "Successfully installed en-core-web-md-2.2.5\n",
      "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
      "You can now load the model via spacy.load('en_core_web_md')\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy download en_core_web_md"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">abstract</br>The prevalence of diabetes is rapidly rising all over the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    globe\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">MULTI-TISSUE_STRUCTURE</span>\n",
       "</mark>\n",
       " at an alarming rate. Over the last three decades, the status of diabetes has been changed, earlier it was considered as a mild disorder of the elderly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    people\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ". Now it becomes a major cause of morbidity and mortality affecting the youth and middle aged \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    people\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ". According to the Diabetes Atlas 2006 published by the International Diabetes Federation, the number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    people\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " with diabetes in India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. The main force of the epidemic of diabetes is the rapid epidemiological transition associated with changes in dietary patterns and decreased physical activity as evident from the higher prevalence of diabetes in the urban population. The most disturbing trend is the shift in age of onset of diabetes to a younger age in the recent years. This could have long lasting adverse effects on nation’s health and economy. Therefore, it is necessary to identify the diabetic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patients\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " at the earliest and provide appropriate lifestyle intervention in preventing or postponing the onset of diabetes. In the present review, detailed mechanism and management of the diabetes have been emphasized.</br></br></br>Key words</br>Diabetes; prevalence; Diabetic acidosis; pathophysiology.</br>INTRODUCTION</br>Diabetes mellitus is not a single disorder, it represents a series of metabolic conditions associated with hyperglycaemia and caused by defects in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " secretion and/or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " action. Exposure to chronic hyperglycaemia may result in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " complications in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    retina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">MULTI-TISSUE_STRUCTURE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " or periphera.</br>Mechanism</br>Diabetes mellitus (DM) is a set of related diseases in which the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    body\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " cannot regulate the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sugar\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " (specifically, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ") in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       ".</br>The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " delivers \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " to provide the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    body\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " with energy to perform all of a person's daily activities. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " converts the food a person eats into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " is then released into the bloodstream. In a healthy person, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " level is regulated by several hormones, primarily \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " is produced by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       ", a small \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    organ\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stomach\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " also makes other important enzymes released directly into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gut\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " that helps digest food. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " allows \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " to move out of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " throughout the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    body\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " where it is used for fuel. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    People\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " suffered diabetes either do not produce enough \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " (type 1 diabetes) or cannot use \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " properly (type 2 diabetes), or both (which occurs with several forms of diabetes). In diabetes, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " cannot move efficiently into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       ", so \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " levels remain high. This not only starves all the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " that need the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " for fuel, but also harms certain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    organs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tissues\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " exposed to the high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " levels.</br>TYPES OF DIABETES</br>There are two main types of diabetes type 1 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    type 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " with their clinical relevance shown in Table 1 and another type of diabetes is gestational diabetes mellitus.</br>Type 1 diabetes</br>Type 1 diabetes is an autoimmune disease in which the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β-cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " do not produce sufficient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", a hormone which helps use \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood sugar\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ") for energy. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " become starved of energy and there will be excess of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       ". This is then followed by life threatening conditions of hypoglycemia, low \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood sugar\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       ", and hyperglycemia, high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood sugar\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       ". When hypoglycemia develops, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " do not get enough \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patients\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " suffer of confusion, loss of consciousness, and coma. Even death can results when the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    brain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " is deprived of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " for too long.</br>Hyperglycemia and prolonged absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " may lead to ketoacidosis, which is accumulation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ketones\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " when the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    body\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " uses \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " for energy instead of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ". This is because \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " cannot be converted into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " at steady state. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ketones\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " make the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " acidic and slow down all \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    body\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBDIVISION</span>\n",
       "</mark>\n",
       " functions. This also leads to a coma and eventually death [1-6].</br>Type 2 diabetes</br>Type 2 diabetes mellitus is a complex endocrine and metabolic disorder. The interaction between several genetic and environmental factors results in a heterogeneous and progressive disorder with variable degrees of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreatic β-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " dysfunction. Overweight and obesity are major contributors to the development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance and impaired \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " tolerance. When β \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " have not longer able to secrete sufficient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " to overcome \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance, impaired \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " tolerance progresses to type-2 diabetes. Abnormalities in other hormones such as reduced secretion of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    incretin glucagon-like\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " peptide 1 (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GLP-1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "), hyperglucagonaemia, and raised concentrations of other counter-regulatory hormones also contribute to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance, reduced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " secretion, and hyper glycaemia in type 2 diabetes[7-13]. Overweight and obesity contribute to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance through several pathways, including an imbalance in the concentrations of hormones (eg, increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leptin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", reduced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adiponectin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", and increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucagon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "), increased concentrations of cytokines (eg, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour necrosis factor α\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    interleukin 6\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "), suppressors of cytokine signalling (eg, suppressor of cytokine signalling), other inflammatory signals, and possibly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    retinol-binding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " protein \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    4.1[14-17\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       "], Concurrent alterations in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " function often include a period of compensatory hyperinsulinaemia with abnormal secretory dynamics. When \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " secretion is no longer sufficient to overcome \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " resistance, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " intolerance progresses to type 2 diabetes. The decline in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " function seems to involve chronic hyperglycaemia (glucotoxicity), chronic exposure to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-esterifies fatty acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " (lipotoxicity), oxidative stress, inflammation, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amyloid formation[18–20\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       "] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Patients\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " with type 2 diabetes usually have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreatic α-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CANCER</span>\n",
       "</mark>\n",
       " dysfunction that results in increased (or nonsuppressed) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucagon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " secretion in the presence of hyperglycaemia and probably reduced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prandial\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " GLP- 1 secretion[21]</br>Gestational diabetes</br>Gestational diabetes mellitus (GDM) is defined as any abnormal carbohydrate intolerance that begins or is first recognized during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pregnancy[22\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "]. It does not exclude the possibility that unidentified \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " intolerance have preceded the pregnant state. GDM complicates approximately 7% of pregnancy, which accounts for more than 2,00,000 cases per \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    year[23\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "]. A recent study from India by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Seshiah\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " et al. reported the incidence of GDM as 18.9%[24]. The clinical importance of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATHOLOGICAL_FORMATION</span>\n",
       "</mark>\n",
       " lies in the fact that it is associated with significant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    maternal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fetal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGAN</span>\n",
       "</mark>\n",
       " morbidity. In the present review we discuss about the pathophysiology, screening, diagnosis, complications and various management issues pertaining to GDM.\n",
       "</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{('4.1[14-17', 'SIMPLE_CHEMICAL'),\n",
      " ('GDM', 'PATHOLOGICAL_FORMATION'),\n",
      " ('GLP-1', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('Insulin', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('Ketones', 'SIMPLE_CHEMICAL'),\n",
      " ('Patients', 'ORGANISM'),\n",
      " ('People', 'ORGANISM'),\n",
      " ('Seshiah', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('adiponectin', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('amyloid formation[18–20', 'ORGANISM'),\n",
      " ('blood', 'ORGANISM_SUBSTANCE'),\n",
      " ('blood glucose', 'ORGANISM_SUBSTANCE'),\n",
      " ('blood sugar', 'ORGANISM_SUBDIVISION'),\n",
      " ('blood sugar', 'ORGANISM_SUBSTANCE'),\n",
      " ('body', 'ORGANISM_SUBDIVISION'),\n",
      " ('brain', 'ORGAN'),\n",
      " ('cells', 'CELL'),\n",
      " ('fat', 'TISSUE'),\n",
      " ('fatty acids', 'SIMPLE_CHEMICAL'),\n",
      " ('fetal', 'ORGAN'),\n",
      " ('globe', 'MULTI-TISSUE_STRUCTURE'),\n",
      " ('glucagon', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('glucagon', 'SIMPLE_CHEMICAL'),\n",
      " ('glucose', 'SIMPLE_CHEMICAL'),\n",
      " ('gut', 'ORGANISM_SUBDIVISION'),\n",
      " ('incretin glucagon-like', 'ORGAN'),\n",
      " ('insulin', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('interleukin 6', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('ketones', 'SIMPLE_CHEMICAL'),\n",
      " ('kidney', 'ORGAN'),\n",
      " ('leptin', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('liver', 'ORGAN'),\n",
      " ('maternal', 'ORGANISM_SUBSTANCE'),\n",
      " ('microvascular', 'TISSUE'),\n",
      " ('non-esterifies fatty acids', 'SIMPLE_CHEMICAL'),\n",
      " ('organ', 'ORGAN'),\n",
      " ('organs', 'ORGAN'),\n",
      " ('pancreas', 'ORGAN'),\n",
      " ('pancreatic α-cell', 'CANCER'),\n",
      " ('pancreatic β-cell', 'CELL'),\n",
      " ('patients', 'ORGANISM'),\n",
      " ('people', 'ORGANISM'),\n",
      " ('prandial', 'SIMPLE_CHEMICAL'),\n",
      " ('pregnancy[22', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('retina', 'MULTI-TISSUE_STRUCTURE'),\n",
      " ('retinol-binding', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('stomach', 'ORGAN'),\n",
      " ('sugar', 'SIMPLE_CHEMICAL'),\n",
      " ('tissues', 'TISSUE'),\n",
      " ('tumour necrosis factor α', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('type 2', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('year[23', 'GENE_OR_GENE_PRODUCT'),\n",
      " ('β-cell', 'CELL'),\n",
      " ('β-cells', 'CELL')}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(None, None)"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "display_entities(en_ner_bionlp13cg_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">abstract</br>The prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is rapidly rising all over the globe at an alarming rate. Over the last three decades, the status of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has been changed, earlier it was considered as a mild \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    disorder of the elderly people. Now it becomes a major\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cause of morbidity and mortality affecting the youth and middle aged people. According to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Atlas 2006 published by the International \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Federation, the number of people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in India currently around 40.9 million is expected to rise to 69.9 million by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    2025\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " unless urgent preventive steps are taken. The main force of the epidemic of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the rapid epidemiological transition associated with changes in dietary patterns and decreased physical activity as evident from the higher prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the urban population. The most disturbing trend is the shift in age of onset of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to a younger age in the recent years. This could have long lasting adverse effects on nation’s health and economy. Therefore, it is necessary to identify the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients at the earliest and provide appropriate lifestyle intervention in preventing or postponing the onset of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the present review, detailed mechanism and management of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been emphasized.</br></br></br>Key words</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; prevalence; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetic acidosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; pathophysiology.</br>INTRODUCTION</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not a single disorder, it represents a series of metabolic conditions associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglycaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and caused by defects in insulin secretion and/or insulin action. Exposure to chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglycaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may result in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular complications\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the retina, kidney or periphera.</br>Mechanism</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is a set of related diseases in which the body cannot regulate the amount of sugar (specifically, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") in the blood.</br>The blood delivers \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to provide the body with energy to perform all of a person's daily activities. The liver converts the food a person eats into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is then released into the bloodstream. In a healthy person, the blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " level is regulated by several hormones, primarily insulin. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is produced by the pancreas, a small organ between the stomach and liver. The pancreas also makes other important enzymes released directly into the gut that helps digest food. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " allows \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to move out of the blood into cells throughout the body where it is used for fuel. People suffered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " either do not produce enough insulin (type 1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or cannot use insulin properly (type 2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or both (which occurs with several forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood cannot move efficiently into cells, so blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels remain high. This not only starves all the cells that need the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for fuel, but also harms certain organs and tissues exposed to the high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels.</br>TYPES OF DIABETES</br>There are two main types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " type 1 and type 2 with their clinical relevance shown in Table 1 and another type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gestational diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".</br>Type 1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "Type 1 diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autoimmune disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in which the β-cells of the pancreas do not produce sufficient insulin, a hormone which helps use blood sugar (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") for energy. The cells become starved of energy and there will be excess of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood. This is then followed by life threatening conditions of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", low blood sugar, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", high blood sugar. When \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " develops, cells do not get enough \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and patients suffer of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Even \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can results when the brain is deprived of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for too long.</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and prolonged absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ketoacidosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which is accumulation of ketones in the blood when the body uses fat for energy instead of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This is because \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cannot be converted into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at steady state. Ketones make the blood acidic and slow down all body functions. This also leads to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and eventually \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " [1-6].</br>Type 2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "Type 2 diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a complex \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocrine and metabolic disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The interaction between several genetic and environmental factors results in a heterogeneous and progressive disorder with variable degrees of insulin resistance and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreatic β-cell dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Overweight and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are major contributors to the development of insulin resistance and impaired \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " tolerance. When β cells have not longer able to secrete sufficient insulin to overcome insulin resistance, impaired \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " tolerance progresses to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    type-2 diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Abnormalities in other hormones such as reduced secretion of the incretin glucagon-like peptide 1 (GLP-1), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglucagonaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and raised concentrations of other counter-regulatory hormones also contribute to insulin resistance, reduced insulin secretion, and hyper glycaemia in type 2 diabetes[7-13]. Overweight and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " contribute to insulin resistance through several pathways, including an imbalance in the concentrations of hormones (eg, increased leptin, reduced adiponectin, and increased glucagon), increased concentrations of cytokines (eg, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour necrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " factor α, interleukin 6), suppressors of cytokine signalling (eg, suppressor of cytokine signalling), other inflammatory signals, and possibly retinol-binding protein 4.1[14-17], Concurrent alterations in β-cell function often include a period of compensatory \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperinsulinaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with abnormal secretory dynamics. When insulin secretion is no longer sufficient to overcome insulin resistance, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intolerance progresses to type 2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The decline in β-cell function seems to involve chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglycaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (glucotoxicity), chronic exposure to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-esterifies fatty acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (lipotoxicity), oxidative stress, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amyloid formation[18–20\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "] Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    type 2 diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " usually have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreatic α-cell dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that results in increased (or nonsuppressed) glucagon secretion in the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperglycaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and probably reduced prandial GLP- 1 secretion[21]</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gestational diabetes\n",
       "Gestational diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is defined as any abnormal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbohydrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intolerance that begins or is first recognized during pregnancy[22]. It does not exclude the possibility that unidentified \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intolerance have preceded the pregnant state. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " complicates approximately 7% of pregnancy, which accounts for more than 2,00,000 cases per year[23]. A recent study from India by Seshiah et al. reported the incidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as 18.9%[24]. The clinical importance of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lies in the fact that it is associated with significant maternal and fetal morbidity. In the present review we discuss about the pathophysiology, screening, diagnosis, complications and various management issues pertaining to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{('2025', 'CHEMICAL'),\n",
      " ('DM', 'DISEASE'),\n",
      " ('Diabetes', 'DISEASE'),\n",
      " ('Diabetes mellitus', 'DISEASE'),\n",
      " ('Diabetic acidosis', 'DISEASE'),\n",
      " ('GDM', 'DISEASE'),\n",
      " ('Gestational diabetes\\nGestational diabetes mellitus', 'DISEASE'),\n",
      " ('Hyperglycemia', 'DISEASE'),\n",
      " ('Insulin', 'CHEMICAL'),\n",
      " ('amyloid formation[18–20', 'CHEMICAL'),\n",
      " ('autoimmune disease', 'DISEASE'),\n",
      " ('carbohydrate', 'CHEMICAL'),\n",
      " ('coma', 'DISEASE'),\n",
      " ('confusion', 'DISEASE'),\n",
      " ('death', 'DISEASE'),\n",
      " ('diabetes', 'DISEASE'),\n",
      " ('diabetes\\nType 1 diabetes', 'DISEASE'),\n",
      " ('diabetes\\nType 2 diabetes mellitus', 'DISEASE'),\n",
      " ('diabetic', 'DISEASE'),\n",
      " ('disorder of the elderly people. Now it becomes a major', 'DISEASE'),\n",
      " ('endocrine and metabolic disorder', 'DISEASE'),\n",
      " ('fatty acids', 'CHEMICAL'),\n",
      " ('gestational diabetes mellitus', 'DISEASE'),\n",
      " ('glucose', 'CHEMICAL'),\n",
      " ('hyperglucagonaemia', 'DISEASE'),\n",
      " ('hyperglycaemia', 'DISEASE'),\n",
      " ('hyperglycemia', 'DISEASE'),\n",
      " ('hyperinsulinaemia', 'DISEASE'),\n",
      " ('hypoglycemia', 'DISEASE'),\n",
      " ('inflammation', 'DISEASE'),\n",
      " ('insulin', 'CHEMICAL'),\n",
      " ('ketoacidosis', 'DISEASE'),\n",
      " ('loss of consciousness', 'DISEASE'),\n",
      " ('microvascular complications', 'DISEASE'),\n",
      " ('non-esterifies fatty acids', 'CHEMICAL'),\n",
      " ('obesity', 'DISEASE'),\n",
      " ('pancreatic α-cell dysfunction', 'DISEASE'),\n",
      " ('pancreatic β-cell dysfunction', 'DISEASE'),\n",
      " ('tumour necrosis', 'DISEASE'),\n",
      " ('type 2 diabetes', 'DISEASE'),\n",
      " ('type-2 diabetes', 'DISEASE')}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(None, None)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "display_entities(en_ner_bc5cdr_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "def show_medical_abbreviation(model,document):\n",
    "    \"\"\" \n",
    "    This function detects and resolves medical abbreviations in word entities\n",
    "\n",
    "    Parameters: \n",
    "         model(module): A pretrained biomedical model from ScispaCy(https://allenai.github.io/scispacy/)\n",
    "         document(str): Document to be processed\n",
    "\n",
    "    Returns: List of unique abbreviations and their resolution \n",
    "     \"\"\"\n",
    "    nlp = model.load()\n",
    "    abbreviation_pipe = AbbreviationDetector(nlp)\n",
    "    nlp.add_pipe(abbreviation_pipe)\n",
    "    doc = nlp(document)\n",
    "    abbreviated = list(set([f\"{abrv}  {abrv._.long_form}\" for abrv in doc._.abbreviations]))             #list is set to ensure only unique values are returned\n",
    "    return abbreviated"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['GDM  Gestational diabetes mellitus',\n",
       " 'DM  Diabetes mellitus',\n",
       " 'GLP-1  glucagon-like peptide 1']"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "show_medical_abbreviation(en_ner_bc5cdr_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['GDM  Gestational diabetes mellitus',\n",
       " 'DM  Diabetes mellitus',\n",
       " 'GLP-1  glucagon-like peptide 1']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "show_medical_abbreviation(en_ner_bionlp13cg_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "def unified_medical_language_entity_linker(model,document):\n",
    "    \"\"\" \n",
    "    This function links named entities to the Unified Medical Language System UMLS (https://www.nlm.nih.gov/research/umls/)\n",
    "\n",
    "    Parameters: \n",
    "         model(module): A pretrained biomedical model from ScispaCy(https://allenai.github.io/scispacy/)\n",
    "         document(str): Document to be processed\n",
    "\n",
    "    Returns: Attributes of Named entities accessible in the Unified Medical Language System database\n",
    "     \"\"\"\n",
    "    nlp = model.load()\n",
    "    linker = UmlsEntityLinker(k=10,max_entities_per_mention = 2)    #parameters are tunable\n",
    "    nlp.add_pipe(linker)\n",
    "    doc = nlp(document)\n",
    "    entity = doc.ents\n",
    "    entity = [str(item) for item in entity]               # convert each entity tuple to list of strings\n",
    "    entity = str(OrderedDict.fromkeys(entity))            # returns unique entities only\n",
    "    entity = nlp(entity).ents                             # convert unique entities back to '.ents' object\n",
    "    for entity in entity:\n",
    "        for umls_ent in entity._.umls_ents:\n",
    "            print(\"Entity Name:\" ,entity)\n",
    "            Concept_Id, Score = umls_ent\n",
    "            print('Concept_Id = {} Score = {}'.format(Concept_Id,Score))\n",
    "            print(linker.umls.cui_to_entity[umls_ent[0]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/data/linking_model/tfidf_vectors_sparse.npz not found in cache, downloading to /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmppsa0sad8\n",
      "Finished download, copying /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmppsa0sad8 to cache at /Users/sdeshpande/.scispacy/datasets/ea855fd121a193f03190a91417c209d4cd97e63d3ce4b456c248ef7c13a4ca77.03518aabd12de2103a27a50302f37c3d87b0f313a8be08b5ec306c9c4334b9b1.tfidf_vectors_sparse.npz\n",
      "https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/data/linking_model/nmslib_index.bin not found in cache, downloading to /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpc15p87vd\n",
      "Finished download, copying /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpc15p87vd to cache at /Users/sdeshpande/.scispacy/datasets/5f620d1bd549a98c005ed601a73806ea2cd1a86ae6c54bbc62bcb3b452ca2630.27a7ac6807fde6628311ff7d70b86fefc640d0eb70637b544c591722a2c16c2a.nmslib_index.bin\n",
      "https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/data/linking_model/tfidf_vectorizer.joblib not found in cache, downloading to /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpuj403_ap\n",
      "Finished download, copying /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpuj403_ap to cache at /Users/sdeshpande/.scispacy/datasets/ffb7a77cdcb3c9233c1e4009c69f38efc13c3619238c508459b5f03fd5f14e4b.9e501319abafbe723d25f1737402d504af6f198fb43b96c85692fa0f9ddc5516.tfidf_vectorizer.joblib\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages/sklearn/base.py:329: UserWarning: Trying to unpickle estimator TfidfTransformer from version 0.20.3 when using version 0.23.1. This might lead to breaking code or invalid results. Use at your own risk.\n",
      "  warnings.warn(\n",
      "/Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages/sklearn/base.py:329: UserWarning: Trying to unpickle estimator TfidfVectorizer from version 0.20.3 when using version 0.23.1. This might lead to breaking code or invalid results. Use at your own risk.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/data/linking_model/concept_aliases.json not found in cache, downloading to /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpn_t19fel\n",
      "Finished download, copying /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpn_t19fel to cache at /Users/sdeshpande/.scispacy/datasets/0f064d20aefab965d5772b2100f8436b3541e7d5313c76cfe5fe070902f149fe.31df9cdb04729860a81bd6c980224ed2bff582586c398d0c9b96ae4e257b9da2.concept_aliases.json\n",
      "https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/data/umls_2017_aa_cat0129.json not found in cache, downloading to /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpmgurgh63\n",
      "Finished download, copying /var/folders/z4/zq1sx9z918l822zf41yhflvr0000gn/T/tmpmgurgh63 to cache at /Users/sdeshpande/.scispacy/datasets/13b30cd31cd37c1b52f3df6ea023061172d16e9941660e677fdbb29489af7410.4ad71d86ce780e00cab131c7e3b81acfd2f11dd80ccd61125c8bcde506f2ab8a.umls_2017_aa_cat0129.json\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages/scispacy/candidate_generation.py:170: VisibleDeprecationWarning: Creating an ndarray from ragged nested sequences (which is a list-or-tuple of lists-or-tuples-or ndarrays with different lengths or shapes) is deprecated. If you meant to do this, you must specify 'dtype=object' when creating the ndarray\n",
      "  extended_neighbors[empty_vectors_boolean_flags] = numpy.array(neighbors)[:-1]\n",
      "/Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages/scispacy/candidate_generation.py:171: VisibleDeprecationWarning: Creating an ndarray from ragged nested sequences (which is a list-or-tuple of lists-or-tuples-or ndarrays with different lengths or shapes) is deprecated. If you meant to do this, you must specify 'dtype=object' when creating the ndarray\n",
      "  extended_distances[empty_vectors_boolean_flags] = numpy.array(distances)[:-1]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Entity Name: Diabetes\n",
      "Concept_Id = C0011849 Score = 1.0\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: Diabetes\n",
      "Concept_Id = C0362046 Score = 0.9028050303459167\n",
      "CUI: C0362046, Name: Prediabetes syndrome\n",
      "Definition: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Prediabetes syndrome, Prediabetic State, Prediabetic State, Prediabetic state, Prediabetic state, prediabetic state, Prediabetic States, States, Prediabetic, State, Prediabetic, Prediabetes\n",
      "Entity Name: Diabetic acidosis\n",
      "Concept_Id = C0011880 Score = 1.0\n",
      "CUI: C0011880, Name: Diabetic Ketoacidosis\n",
      "Definition: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 59): \n",
      "\t Diabetic Ketoacidosis, Diabetic Ketoacidosis, Diabetic Ketoacidosis, Diabetic Ketoacidosis, Diabetic Ketoacidosis, KETOACIDOSIS, DIABETIC, KETOACIDOSIS, DIABETIC, DIABETIC KETOACIDOSIS, DIABETIC KETOACIDOSIS, Diabetic ketoacidosis\n",
      "Entity Name: Diabetes mellitus\n",
      "Concept_Id = C0011849 Score = 0.9999998807907104\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: Diabetes mellitus\n",
      "Concept_Id = C0011878 Score = 0.8892595767974854\n",
      "CUI: C0011878, Name: Diabetic Diet\n",
      "Definition: A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX.\n",
      "TUI(s): T061\n",
      "Aliases (abbreviated, total: 13): \n",
      "\t Diabetic Diet, Diabetic Diet, Diabetic diet, diabetic diet, diabetic diet, Diabetic Diets, Diets, Diabetic, diabetic diets, Diet, Diabetic, DD - Diabetic diet\n",
      "Entity Name: hyperglycaemia\n",
      "Concept_Id = C0020456 Score = 1.0\n",
      "CUI: C0020456, Name: Hyperglycemia\n",
      "Definition: Abnormally high BLOOD GLUCOSE level.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 53): \n",
      "\t Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia\n",
      "Entity Name: hyperglycaemia\n",
      "Concept_Id = C0475718 Score = 0.862811803817749\n",
      "CUI: C0475718, Name: Neonatal hyperglycemia\n",
      "Definition: Blood glucose concentration above the upper limit of established reference ranges in a newborn.(NICHD)\n",
      "TUI(s): T047\n",
      "Aliases: (total: 5): \n",
      "\t neonatal hyperglycemia, Neonatal Hyperglycemia, Neonatal Hyperglycemia, Neonatal hyperglycaemia, Neonatal hyperglycemia (disorder)\n",
      "Entity Name: microvascular complications\n",
      "Concept_Id = C0161816 Score = 0.7498036623001099\n",
      "CUI: C0161816, Name: Cardiac complication\n",
      "Definition: Any heart or vascular disorder occurring as a consequence of injury to the cardiovascular system.\n",
      "TUI(s): T046\n",
      "Aliases (abbreviated, total: 11): \n",
      "\t cardiac complication, Cardiac complications, Cardiac complication, NOS, cardiac complications, complications cardiac, Cardiac complications of care, complication heart, complications heart, Cardiac complication (disorder), cardiovascular complications\n",
      "Entity Name: DM\n",
      "Concept_Id = C0011777 Score = 0.9999998807907104\n",
      "CUI: C0011777, Name: Dexamethasone\n",
      "Definition: An anti-inflammatory 9-fluoro-glucocorticoid.\n",
      "TUI(s): T109, T121\n",
      "Aliases (abbreviated, total: 90): \n",
      "\t Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone, Dexamethasone\n",
      "Entity Name: DM\n",
      "Concept_Id = C1704791 Score = 0.9999998807907104\n",
      "CUI: C1704791, Name: Demographics Domain\n",
      "Definition: A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to demographics.\n",
      "TUI(s): T078\n",
      "Aliases: (total: 3): \n",
      "\t Demographics Domain, Demographics, DM\n",
      "Entity Name: glucose\n",
      "Concept_Id = C0017725 Score = 1.0\n",
      "CUI: C0017725, Name: Glucose\n",
      "Definition: A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.\n",
      "TUI(s): T109, T121, T123\n",
      "Aliases (abbreviated, total: 86): \n",
      "\t Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose\n",
      "Entity Name: glucose\n",
      "Concept_Id = C0337438 Score = 1.0\n",
      "CUI: C0337438, Name: Glucose measurement\n",
      "Definition: The determination of the amount of glucose present in a sample.\n",
      "TUI(s): T059\n",
      "Aliases (abbreviated, total: 19): \n",
      "\t Glucose measurement, Glucose measurement, Glucose Measurement, glucose measurement, Glucose measurement, NOS, glucose measurements, Glucose, Glucose, Glucose, Glucose\n",
      "Entity Name: gestational diabetes mellitus\n",
      "Concept_Id = C0085207 Score = 1.0\n",
      "CUI: C0085207, Name: Gestational Diabetes\n",
      "Definition: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 48): \n",
      "\t Gestational Diabetes, Gestational Diabetes, Gestational Diabetes, Gestational Diabetes, Gestational diabetes, Gestational diabetes, Gestational diabetes, gestational diabetes, gestational diabetes, gestational diabetes\n",
      "Entity Name: gestational diabetes mellitus\n",
      "Concept_Id = C4289216 Score = 0.8771894574165344\n",
      "CUI: C4289216, Name: GAIA Level 1 Gestational Diabetes Mellitus\n",
      "Definition: GAIA Level 1 Gestational Diabetes Mellitus is defined by three criteria: first, at least one of the following requirements must be met: a) the absence of a previous diagnosis of diabetes while not pregnant; b) a first trimester hemoglobin A1c level of greater than or equal to 6.5% (47.5 mmol/mol); c) a first trimester fasting blood glucose greater than or equal to 126 mg/dL (greater than 7mmol/L); second, gestational age with level 1 or level 2 certainty, using the GAIA definition for gestational age; third, a diagnosis of gestational diabetes as determined by a positive result from an international standard oral glucose tolerance test using venous blood samples.\n",
      "TUI(s): T170\n",
      "Aliases: (total: 2): \n",
      "\t Global Alignment of Immunization Level 1 Gestational Diabetes Mellitus, Level 1 Gestational Diabetes Mellitus\n",
      "Entity Name: diabetes\n",
      "Concept_Id = C0011849 Score = 1.0\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: diabetes\n",
      "Concept_Id = C0362046 Score = 0.9028050303459167\n",
      "CUI: C0362046, Name: Prediabetes syndrome\n",
      "Definition: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Prediabetes syndrome, Prediabetic State, Prediabetic State, Prediabetic state, Prediabetic state, prediabetic state, Prediabetic States, States, Prediabetic, State, Prediabetic, Prediabetes\n",
      "Entity Name: autoimmune disease\n",
      "Concept_Id = C0004364 Score = 1.0\n",
      "CUI: C0004364, Name: Autoimmune Diseases\n",
      "Definition: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 52): \n",
      "\t Autoimmune Diseases, Autoimmune Diseases, Autoimmune Diseases, Autoimmune Diseases, Autoimmune diseases, Autoimmune diseases, Autoimmune diseases, Autoimmune diseases, autoimmune diseases, Autoimmune disease\n",
      "Entity Name: hypoglycemia\n",
      "Concept_Id = C0020615 Score = 1.0\n",
      "CUI: C0020615, Name: Hypoglycemia\n",
      "Definition: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 57): \n",
      "\t Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia, Hypoglycemia\n",
      "Entity Name: hypoglycemia\n",
      "Concept_Id = C0020616 Score = 0.8907233476638794\n",
      "CUI: C0020616, Name: Hypoglycemic Agents\n",
      "Definition: Substances which lower blood glucose levels.\n",
      "TUI(s): T121\n",
      "Aliases (abbreviated, total: 30): \n",
      "\t Hypoglycemic agents, Hypoglycemic agents, hypoglycemic agents, hypoglycemic agent, Hypoglycaemic agent, Hypoglycemic agent, Agents, Hypoglycemic, Hypoglycemic Drugs, Hypoglycemic Drugs, hypoglycemic drugs\n",
      "Entity Name: hyperglycemia\n",
      "Concept_Id = C0020456 Score = 1.0\n",
      "CUI: C0020456, Name: Hyperglycemia\n",
      "Definition: Abnormally high BLOOD GLUCOSE level.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 53): \n",
      "\t Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia\n",
      "Entity Name: confusion\n",
      "Concept_Id = C0009676 Score = 1.0\n",
      "CUI: C0009676, Name: Confusion\n",
      "Definition: A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.\n",
      "TUI(s): T048\n",
      "Aliases (abbreviated, total: 51): \n",
      "\t Confusion, Confusion, Confusion, Confusion, Confusion, Confusion, Confusion, Confusion, Confusion, Confusion\n",
      "Entity Name: 'loss of consciousness\n",
      "Concept_Id = C0041657 Score = 0.9840325713157654\n",
      "CUI: C0041657, Name: Unconscious State\n",
      "Definition: Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5)\n",
      "TUI(s): T033\n",
      "Aliases (abbreviated, total: 50): \n",
      "\t Unconscious State, Unconscious State, Unconscious State, Unconscious State, Unconscious States, State, Unconscious, Consciousness, Loss of, Consciousness, Loss of, Loss of consciousness, Loss of consciousness\n",
      "Entity Name: 'loss of consciousness\n",
      "Concept_Id = C0234421 Score = 0.9081322550773621\n",
      "CUI: C0234421, Name: Conscious\n",
      "Definition: Sense of awareness of self and of the environment.\n",
      "TUI(s): T041\n",
      "Aliases (abbreviated, total: 20): \n",
      "\t Conscious, Conscious, Conscious, Conscious, CONSCIOUS, conscious, conscious, Consciousness, Consciousness, Consciousness\n",
      "Entity Name: coma\n",
      "Concept_Id = C0009421 Score = 1.0\n",
      "CUI: C0009421, Name: Comatose\n",
      "Definition: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 38): \n",
      "\t Comatose, Comatose, Comatose, Comatose, Comatose, Comatose, comatose, Coma, Coma, Coma\n",
      "Entity Name: coma\n",
      "Concept_Id = C0151294 Score = 0.7164358496665955\n",
      "CUI: C0151294, Name: Coma or pre-coma\n",
      "Definition: WHAT: Coma.\tComa: a state of prolonged unconsciousness from which the patient cannot be aroused or can only be aroused for short periods. Focal neurological signs, spinal fluid abnormalities, or blood chemistry and toxicology disturbances may also be present.\tWHY:\tComa may be caused by systemic lupus erythematosus or acetylsalicylic acid toxicity, among other causes.\tHOW:\tComa is present when the responses to auditory, visual, olfactory, and tactile stimuli are substantially diminished. The evaluation of this condition requires a special type of investigative history, a full physical evaluation, and laboratory studies of the blood and spinal fluid.\tREFS:\tAdams, RD: \"Coma and Related Disturbances of Consciousness\". In Harrison's Principles of Internal Medicine (Ch. 22). New York: McGraw-Hill Book Co., 1977.\n",
      "TUI(s): T047\n",
      "Aliases: (total: 0): \n",
      "\t \n",
      "Entity Name: death\n",
      "Concept_Id = C0011065 Score = 0.9999999403953552\n",
      "CUI: C0011065, Name: Cessation of life\n",
      "Definition: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.\n",
      "TUI(s): T040\n",
      "Aliases (abbreviated, total: 39): \n",
      "\t Death, Death, Death, Death, Death, Death, Death, Death, Death, Death\n",
      "Entity Name: death\n",
      "Concept_Id = C1559081 Score = 0.9999999403953552\n",
      "CUI: C1559081, Name: Adverse Event Associated with Death\n",
      "Definition: An adverse event resulting in death.\n",
      "TUI(s): T033\n",
      "Aliases: (total: 2): \n",
      "\t Adverse Event Associated with Death, DEATH\n",
      "Entity Name: Hyperglycemia\n",
      "Concept_Id = C0020456 Score = 1.0\n",
      "CUI: C0020456, Name: Hyperglycemia\n",
      "Definition: Abnormally high BLOOD GLUCOSE level.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 53): \n",
      "\t Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia, Hyperglycemia\n",
      "Entity Name: ketoacidosis\n",
      "Concept_Id = C0022638 Score = 1.0\n",
      "CUI: C0022638, Name: Ketosis\n",
      "Definition: A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 16): \n",
      "\t Ketosis, Ketosis, Ketosis, Ketosis, Ketosis, Ketosis, Ketosis, KETOSIS, KETOSIS, ketosis\n",
      "Entity Name: ketoacidosis\n",
      "Concept_Id = C0220982 Score = 1.0\n",
      "CUI: C0220982, Name: Ketoacidosis\n",
      "Definition: Acidosis resulting from accumulation of ketone bodies. [HPO:probinson]\n",
      "TUI(s): T046\n",
      "Aliases (abbreviated, total: 13): \n",
      "\t Ketoacidosis, Ketoacidosis, Ketoacidosis, Ketoacidosis, Ketoacidosis, KETOACIDOSIS, KETOACIDOSIS, ketoacidosis, ketoacidosis, Ketoacidosis, NOS\n",
      "Entity Name: diabetes mellitus\n",
      "Concept_Id = C0011849 Score = 0.9999998807907104\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: diabetes mellitus\n",
      "Concept_Id = C0011878 Score = 0.8892595767974854\n",
      "CUI: C0011878, Name: Diabetic Diet\n",
      "Definition: A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX.\n",
      "TUI(s): T061\n",
      "Aliases (abbreviated, total: 13): \n",
      "\t Diabetic Diet, Diabetic Diet, Diabetic diet, diabetic diet, diabetic diet, Diabetic Diets, Diets, Diabetic, diabetic diets, Diet, Diabetic, DD - Diabetic diet\n",
      "Entity Name: metabolic disorder\n",
      "Concept_Id = C0025517 Score = 1.0\n",
      "CUI: C0025517, Name: Metabolic Diseases\n",
      "Definition: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 36): \n",
      "\t Metabolic Diseases, metabolic diseases, Disease, Metabolic, Metabolic Disease, Metabolic Disease, Metabolic Disease, Metabolic disease, Metabolic disease, Metabolic disease, NOS, metabolic disease\n",
      "Entity Name: metabolic disorder\n",
      "Concept_Id = C0005944 Score = 0.9107848405838013\n",
      "CUI: C0005944, Name: Metabolic Bone Disorder\n",
      "Definition: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 25): \n",
      "\t Metabolic Bone Disorder, metabolic bone disorder, Metabolic disorder of bone, bone disorders metabolic, metabolic bone disorders, Bone Diseases, Metabolic, Bone Diseases, Metabolic, metabolic bone diseases, Bone Disease, Metabolic, Disease, Metabolic Bone\n",
      "Entity Name: type-2 diabetes\n",
      "Concept_Id = C0011854 Score = 0.729732096195221\n",
      "CUI: C0011854, Name: Diabetes Mellitus, Insulin-Dependent\n",
      "Definition: A chronic condition characterized by minimal or absent production of insulin by the pancreas.(NICHD)\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 126): \n",
      "\t Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, Insulin dependent diabetes mellitus, Insulin dependent diabetes mellitus, Insulin dependent diabetes mellitus, Insulin dependent diabetes mellitus, Insulin dependent diabetes mellitus, insulin dependent diabetes mellitus, insulin dependent diabetes mellitus, Insulin-dependent diabetes mellitus\n",
      "Entity Name: type-2 diabetes\n",
      "Concept_Id = C0011860 Score = 0.7225965261459351\n",
      "CUI: C0011860, Name: Diabetes Mellitus, Non-Insulin-Dependent\n",
      "Definition: A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 156): \n",
      "\t Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent, Non-insulin dependent diabetes mellitus, non-insulin dependent diabetes mellitus, DIABETES MELLITUS, NON-INSULIN DEPENDENT, Diabetes Mellitus, Non Insulin Dependent, Diabetes Mellitus, Non Insulin Dependent, Non-Insulin-Dependent Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus\n",
      "Entity Name: tumour necrosis\n",
      "Concept_Id = C0333516 Score = 1.0\n",
      "CUI: C0333516, Name: Tumor necrosis\n",
      "Definition: The lysis (breakdown) of cancer cells. This can be caused by chemical or physical means (for example, strong detergents or high-energy sound waves) or by infection with a strain of virus that can lyse cells.\n",
      "TUI(s): T191\n",
      "Aliases (abbreviated, total: 19): \n",
      "\t Tumor necrosis, Necrosis, tumor, necrosis tumor, tumor necrosis, Tumour necrosis, Tumour necrosis, necrosis tumour, tumour necrosis, Neoplasm necrosis, Neoplasm necrosis\n",
      "Entity Name: tumour necrosis\n",
      "Concept_Id = C0041368 Score = 0.8753199577331543\n",
      "CUI: C0041368, Name: Tumor Necrosis Factors\n",
      "Definition: A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.\n",
      "TUI(s): T116, T129\n",
      "Aliases (abbreviated, total: 31): \n",
      "\t Tumor Necrosis Factors, Tumor Necrosis Factors, Tumor Necrosis Factors, Tumor Necrosis Factors, tumor necrosis factor, tumor necrosis factor, tumor necrosis factor, Tumor necrosis factor, tumour necrosis factor, Necrosis Factors, Tumor\n",
      "Entity Name: hyperinsulinaemia\n",
      "Concept_Id = C0020459 Score = 1.0\n",
      "CUI: C0020459, Name: Hyperinsulinism\n",
      "Definition: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 28): \n",
      "\t Hyperinsulinism, Hyperinsulinism, Hyperinsulinism, hyperinsulinism, hyperinsulinism, Hyperinsulinism, NOS, Hyperinsulinism NOS, Hyperinsulinemia, Hyperinsulinemia, Hyperinsulinemia\n",
      "Entity Name: hyperinsulinaemia\n",
      "Concept_Id = C0852795 Score = 0.8203614354133606\n",
      "CUI: C0852795, Name: Increased insulin level\n",
      "Definition: Abnormally high levels of insulin in the blood.\n",
      "TUI(s): T033\n",
      "Aliases: (total: 7): \n",
      "\t Increased insulin level, Hyperinsulinism, Hyperinsulinemia, Hyperinsulinemia, Hyperinsulinemia, Serum insulin concentration increased above normal, Increased insulin level (finding)\n",
      "Entity Name: inflammation\n",
      "Concept_Id = C0021368 Score = 1.0\n",
      "CUI: C0021368, Name: Inflammation\n",
      "Definition: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.\n",
      "TUI(s): T046\n",
      "Aliases (abbreviated, total: 30): \n",
      "\t Inflammation, Inflammation, Inflammation, Inflammation, Inflammation, Inflammation, Inflammation, Inflammation, Inflammation, Inflammation\n",
      "Entity Name: inflammation\n",
      "Concept_Id = C0029400 Score = 0.897955060005188\n",
      "CUI: C0029400, Name: Osteitis\n",
      "Definition: Inflammation of the bone.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 24): \n",
      "\t Osteitis, Osteitis, Osteitis, Osteitis, Osteitis, Osteitis, osteitis, osteitis, Osteitis, NOS, Bone Inflammation\n",
      "Entity Name: diabetes\n",
      "Concept_Id = C0011849 Score = 1.0\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: diabetes\n",
      "Concept_Id = C0362046 Score = 0.9028050303459167\n",
      "CUI: C0362046, Name: Prediabetes syndrome\n",
      "Definition: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Prediabetes syndrome, Prediabetic State, Prediabetic State, Prediabetic state, Prediabetic state, prediabetic state, Prediabetic States, States, Prediabetic, State, Prediabetic, Prediabetes\n",
      "Entity Name: diabetes mellitus\n",
      "Concept_Id = C0011849 Score = 0.9999998807907104\n",
      "CUI: C0011849, Name: Diabetes Mellitus\n",
      "Definition: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, Diabetes Mellitus, DIABETES MELLITUS, DIABETES MELLITUS, DIABETES MELLITUS\n",
      "Entity Name: diabetes mellitus\n",
      "Concept_Id = C0011878 Score = 0.8892595767974854\n",
      "CUI: C0011878, Name: Diabetic Diet\n",
      "Definition: A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX.\n",
      "TUI(s): T061\n",
      "Aliases (abbreviated, total: 13): \n",
      "\t Diabetic Diet, Diabetic Diet, Diabetic diet, diabetic diet, diabetic diet, Diabetic Diets, Diets, Diabetic, diabetic diets, Diet, Diabetic, DD - Diabetic diet\n",
      "Entity Name: GDM\n",
      "Concept_Id = C0085207 Score = 1.0\n",
      "CUI: C0085207, Name: Gestational Diabetes\n",
      "Definition: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 48): \n",
      "\t Gestational Diabetes, Gestational Diabetes, Gestational Diabetes, Gestational Diabetes, Gestational diabetes, Gestational diabetes, Gestational diabetes, gestational diabetes, gestational diabetes, gestational diabetes\n"
     ]
    }
   ],
   "source": [
    "unified_medical_language_entity_linker(en_ner_bc5cdr_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Entity Name: people\n",
      "Concept_Id = C0027361 Score = 1.0\n",
      "CUI: C0027361, Name: Persons\n",
      "Definition: Persons as individuals (e.g., ABORTION APPLICANTS) or as members of a group (e.g., HISPANIC AMERICANS). It is not used for members of the various professions (e.g., PHYSICIANS) or occupations (e.g., LIBRARIANS) for which OCCUPATIONAL GROUPS is available.\n",
      "TUI(s): T098\n",
      "Aliases (abbreviated, total: 21): \n",
      "\t Persons, Persons, persons, Person, Person, Person, Person, Person, Person, Person\n",
      "Entity Name: people\n",
      "Concept_Id = C0152035 Score = 0.7433323264122009\n",
      "CUI: C0152035, Name: Chinese People\n",
      "Definition: A person having origins in any of the original peoples of China.\n",
      "TUI(s): T098\n",
      "Aliases (abbreviated, total: 14): \n",
      "\t chinese people, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, CHINESE\n",
      "Entity Name: patients\n",
      "Concept_Id = C0030705 Score = 0.9999999403953552\n",
      "CUI: C0030705, Name: Patients\n",
      "Definition: Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.\n",
      "TUI(s): T101\n",
      "Aliases (abbreviated, total: 25): \n",
      "\t Patients, Patients, Patients, Patients, patients, Patient, Patient, Patient, Patient, Patient\n",
      "Entity Name: patients\n",
      "Concept_Id = C0025360 Score = 0.8272134065628052\n",
      "CUI: C0025360, Name: Mentally Ill Persons\n",
      "Definition: Persons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.\n",
      "TUI(s): T101\n",
      "Aliases (abbreviated, total: 11): \n",
      "\t Mentally Ill Person, Person, Mentally Ill, Persons, Mentally Ill, Mental Patients, mental patients, mental patient, Mentally Ill, mentally ill, mentally ill, Mentally ill\n",
      "Entity Name: insulin\n",
      "Concept_Id = C0021641 Score = 1.0\n",
      "CUI: C0021641, Name: Insulin\n",
      "Definition: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases (abbreviated, total: 58): \n",
      "\t Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin\n",
      "Entity Name: insulin\n",
      "Concept_Id = C1533581 Score = 1.0\n",
      "CUI: C1533581, Name: Recombinant Insulin\n",
      "Definition: A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus. Therapeutic insulin is formulated to be short-, intermediate- and long-acting in order to individualize an insulin regimen according to individual differences in glucose and insulin metabolism. Therapeutic insulin may be derived from porcine, bovine or recombinant sources. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases: (total: 5): \n",
      "\t Recombinant Insulin, Insulin, Insulin, INSULIN, Therapeutic Insulin\n",
      "Entity Name: microvascular\n",
      "Concept_Id = C1513268 Score = 0.8860355019569397\n",
      "CUI: C1513268, Name: Microcirculatory Bed\n",
      "Definition: A collection of the smallest blood vessels of the vascular system, which are involved in the exchange of gases, water, nutrients, and waste products, and which includes blood vessels from the first-order arteriole to the first-order venule.\n",
      "TUI(s): T023\n",
      "Aliases: (total: 1): \n",
      "\t Microvascular Bed\n",
      "Entity Name: microvascular\n",
      "Concept_Id = C0206064 Score = 0.8503652215003967\n",
      "CUI: C0206064, Name: Microvascular Angina\n",
      "Definition: ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.\n",
      "TUI(s): T047\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Microvascular Angina, microvascular angina, Angina, Microvascular, Angina, Microvascular, Angina Pectoris with Normal Coronary Arteriogram, Angina Pectoris with Normal Coronary Arteriogram, syndrome x, Chest pain with normal coronary angiography, Syndrome X, Cardiac, Syndrome X, Cardiac\n",
      "Entity Name: kidney\n",
      "Concept_Id = C0022646 Score = 1.0\n",
      "CUI: C0022646, Name: Kidney\n",
      "Definition: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 47): \n",
      "\t Kidney, Kidney, Kidney, Kidney, Kidney, Kidney, Kidney, Kidney, Kidney, Kidney\n",
      "Entity Name: kidney\n",
      "Concept_Id = C1514845 Score = 1.0\n",
      "CUI: C1514845, Name: Renal Tissue\n",
      "Definition: Tissue composed of the renal cortex and the renal medulla. The basic functional unit of renal tissue is the nephron.\n",
      "TUI(s): T024\n",
      "Aliases: (total: 2): \n",
      "\t Renal Tissue, KIDNEY\n",
      "Entity Name: glucose\n",
      "Concept_Id = C0017725 Score = 1.0\n",
      "CUI: C0017725, Name: Glucose\n",
      "Definition: A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.\n",
      "TUI(s): T109, T121, T123\n",
      "Aliases (abbreviated, total: 86): \n",
      "\t Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose, Glucose\n",
      "Entity Name: glucose\n",
      "Concept_Id = C0337438 Score = 1.0\n",
      "CUI: C0337438, Name: Glucose measurement\n",
      "Definition: The determination of the amount of glucose present in a sample.\n",
      "TUI(s): T059\n",
      "Aliases (abbreviated, total: 19): \n",
      "\t Glucose measurement, Glucose measurement, Glucose Measurement, glucose measurement, Glucose measurement, NOS, glucose measurements, Glucose, Glucose, Glucose, Glucose\n",
      "Entity Name: blood\n",
      "Concept_Id = C0229664 Score = 1.0\n",
      "CUI: C0229664, Name: peripheral blood\n",
      "Definition: A tissue with red blood cells, white blood cells, platelets, and other substances suspended in fluid called plasma. Blood takes oxygen and nutrients to the tissues, and carries away wastes.\n",
      "TUI(s): T031\n",
      "Aliases (abbreviated, total: 18): \n",
      "\t peripheral blood, peripheral blood, Blood - peripheral, Peripheral blood, Peripheral blood, Peripheral Blood, Peripheral Blood, Peripheral Blood, Peripheral blood, NOS, blood peripheral\n",
      "Entity Name: blood\n",
      "Concept_Id = C0005767 Score = 1.0\n",
      "CUI: C0005767, Name: Blood\n",
      "Definition: The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.\n",
      "TUI(s): T031\n",
      "Aliases (abbreviated, total: 24): \n",
      "\t Blood, Blood, Blood, Blood, Blood, Blood, Blood, Blood, Blood, Blood\n",
      "Entity Name: liver\n",
      "Concept_Id = C2346688 Score = 1.0\n",
      "CUI: C2346688, Name: Liver Flavor\n",
      "Definition: A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory receptors resembles liver.\n",
      "TUI(s): T168\n",
      "Aliases: (total: 2): \n",
      "\t Liver Flavor, LIVER\n",
      "Entity Name: liver\n",
      "Concept_Id = C0023884 Score = 1.0\n",
      "CUI: C0023884, Name: Liver\n",
      "Definition: A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 36): \n",
      "\t Liver, Liver, Liver, Liver, Liver, Liver, Liver, Liver, Liver, Liver\n",
      "Entity Name: blood glucose\n",
      "Concept_Id = C0392201 Score = 1.0\n",
      "CUI: C0392201, Name: Blood glucose measurement\n",
      "Definition: A quantitative measurement for assessing the amount of glucose present in a blood sample.\n",
      "TUI(s): T059\n",
      "Aliases (abbreviated, total: 25): \n",
      "\t Glucose measurement, blood, Glucose measurement, blood, Glucose, blood, measurement, Glucose Measurement, Blood, Blood Glucose Measurement, Blood Glucose Measurement, blood glucose measurement, blood glucose measurements, Blood Glucose, blood glucose\n",
      "Entity Name: blood glucose\n",
      "Concept_Id = C0005802 Score = 1.0\n",
      "CUI: C0005802, Name: Blood Glucose\n",
      "Definition: Glucose in blood.\n",
      "TUI(s): T109\n",
      "Aliases (abbreviated, total: 22): \n",
      "\t Blood Glucose, Blood Glucose, Blood Glucose, Blood Glucose, glucose blood, blood glucose, blood glucose, Glucose, Blood, Glucose, Blood, Blood Sugar\n",
      "Entity Name: Insulin\n",
      "Concept_Id = C0021641 Score = 1.0\n",
      "CUI: C0021641, Name: Insulin\n",
      "Definition: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases (abbreviated, total: 58): \n",
      "\t Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin, Insulin\n",
      "Entity Name: Insulin\n",
      "Concept_Id = C1533581 Score = 1.0\n",
      "CUI: C1533581, Name: Recombinant Insulin\n",
      "Definition: A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus. Therapeutic insulin is formulated to be short-, intermediate- and long-acting in order to individualize an insulin regimen according to individual differences in glucose and insulin metabolism. Therapeutic insulin may be derived from porcine, bovine or recombinant sources. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases: (total: 5): \n",
      "\t Recombinant Insulin, Insulin, Insulin, INSULIN, Therapeutic Insulin\n",
      "Entity Name: pancreas\n",
      "Concept_Id = C0030274 Score = 0.9999998807907104\n",
      "CUI: C0030274, Name: Pancreas\n",
      "Definition: A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 38): \n",
      "\t Pancreas, Pancreas, Pancreas, Pancreas, Pancreas, Pancreas, Pancreas, Pancreas, Pancreas, Pancreas\n",
      "Entity Name: pancreas\n",
      "Concept_Id = C0346647 Score = 0.8993453979492188\n",
      "CUI: C0346647, Name: Malignant neoplasm of pancreas\n",
      "Definition: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003\n",
      "TUI(s): T191\n",
      "Aliases (abbreviated, total: 46): \n",
      "\t Malignant neoplasm of pancreas, Malignant Neoplasm of Pancreas, malignant neoplasm of pancreas, PANCREAS NEOPLASM MALIGNANT, PANCREAS NEOPLASM MALIGNANT, Malignant neoplasm pancreas, Malignant neoplasm of pancreas, NOS, Malignant Neoplasm of the Pancreas, Pancreatic Cancer, Pancreatic Cancer\n",
      "Entity Name: organ\n",
      "Concept_Id = C0178784 Score = 1.0\n",
      "CUI: C0178784, Name: Organ\n",
      "Definition: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 14): \n",
      "\t Organ, Organ, Organ, Organ, organ, organ, organ, organs, {Organ}, {Organ}\n",
      "Entity Name: organ\n",
      "Concept_Id = C0927230 Score = 0.8018884062767029\n",
      "CUI: C0927230, Name: Organ with organ cavity\n",
      "Definition: Cavitated organ in which its unshared parts surround one continuous anatomical space. Examples: stomach, urinary bladder, esophagus, uterine tube.\n",
      "TUI(s): T023\n",
      "Aliases: (total: 1): \n",
      "\t Organ with organ cavity\n",
      "Entity Name: stomach\n",
      "Concept_Id = C0038351 Score = 1.0\n",
      "CUI: C0038351, Name: Stomach\n",
      "Definition: An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 35): \n",
      "\t Stomach, Stomach, Stomach, Stomach, Stomach, Stomach, Stomach, Stomach, Stomach, Stomach\n",
      "Entity Name: stomach\n",
      "Concept_Id = C1517454 Score = 1.0\n",
      "CUI: C1517454, Name: Gastric Tissue\n",
      "Definition: The tissue of the stomach. It is composed of a fibrous outer layer bounded by smooth muscle, the submucosa, and the mucosa. The mucosa of the stomach consists of secretory cells that produce hydrochloric acid and gastric enzymes.\n",
      "TUI(s): T024\n",
      "Aliases: (total: 2): \n",
      "\t Gastric Tissue, STOMACH\n",
      "Entity Name: gut\n",
      "Concept_Id = C0021853 Score = 1.0\n",
      "CUI: C0021853, Name: Intestines\n",
      "Definition: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 54): \n",
      "\t Intestines, Intestines, Intestines, Intestines, Intestines, intestines, Intestine, Intestine, Intestine, Intestine\n",
      "Entity Name: gut\n",
      "Concept_Id = C0017189 Score = 1.0\n",
      "CUI: C0017189, Name: Gastrointestinal tract structure\n",
      "Definition: Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).\n",
      "TUI(s): T022\n",
      "Aliases (abbreviated, total: 55): \n",
      "\t Gastrointestinal tract structure, Gastrointestinal system, Gastrointestinal Tract, Gastrointestinal Tract, Gastrointestinal Tract, Gastrointestinal Tract, Gastrointestinal Tract, Gastrointestinal tract, Gastrointestinal tract, Gastrointestinal tract\n",
      "Entity Name: cells\n",
      "Concept_Id = C0007634 Score = 0.9999999403953552\n",
      "CUI: C0007634, Name: Cells\n",
      "Definition: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.\n",
      "TUI(s): T025\n",
      "Aliases (abbreviated, total: 41): \n",
      "\t Cells, Cells, Cells, Cells, Cells, Cells, Cells, Cells, cells, cells\n",
      "Entity Name: cells\n",
      "Concept_Id = C0023172 Score = 0.9056758284568787\n",
      "CUI: C0023172, Name: Lupus erythematosus cell\n",
      "Definition: The lupus erythematosus cell, which is likely a neutrophil with denatured nuclei. It may be found in blood, bone marrow, synovial fluid, cerebrospinal fluid, pericardial and pleural effusions of individuals with lupus erythematosus.\n",
      "TUI(s): T025\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Lupus erythematosus cell, Lupus erythematosus cell, Lupus erythematosus cell, Lupus erythematosus cell, lupus erythematosus cell, Lupus Erythematosus Cell, Lupus Erythematosus Cell, cells erythematosus lupus, Lupus erythematosus cells, Lupus erythematosus cells\n",
      "Entity Name: People\n",
      "Concept_Id = C0027361 Score = 1.0\n",
      "CUI: C0027361, Name: Persons\n",
      "Definition: Persons as individuals (e.g., ABORTION APPLICANTS) or as members of a group (e.g., HISPANIC AMERICANS). It is not used for members of the various professions (e.g., PHYSICIANS) or occupations (e.g., LIBRARIANS) for which OCCUPATIONAL GROUPS is available.\n",
      "TUI(s): T098\n",
      "Aliases (abbreviated, total: 21): \n",
      "\t Persons, Persons, persons, Person, Person, Person, Person, Person, Person, Person\n",
      "Entity Name: People\n",
      "Concept_Id = C0152035 Score = 0.7433323264122009\n",
      "CUI: C0152035, Name: Chinese People\n",
      "Definition: A person having origins in any of the original peoples of China.\n",
      "TUI(s): T098\n",
      "Aliases (abbreviated, total: 14): \n",
      "\t chinese people, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, Chinese, CHINESE\n",
      "Entity Name: organs\n",
      "Concept_Id = C0178784 Score = 1.0\n",
      "CUI: C0178784, Name: Organ\n",
      "Definition: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 14): \n",
      "\t Organ, Organ, Organ, Organ, organ, organ, organ, organs, {Organ}, {Organ}\n",
      "Entity Name: organs\n",
      "Concept_Id = C1182742 Score = 0.7942999601364136\n",
      "CUI: C1182742, Name: Set of organs\n",
      "Definition: Anatomical set which has as its direct members organs of same type or of different types.\n",
      "TUI(s): T023\n",
      "Aliases: (total: 2): \n",
      "\t Set of organs, Organs set\n",
      "Entity Name: tissues\n",
      "Concept_Id = C0040300 Score = 1.0\n",
      "CUI: C0040300, Name: Body tissue\n",
      "Definition: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.\n",
      "TUI(s): T024\n",
      "Aliases (abbreviated, total: 34): \n",
      "\t Body tissue, Body tissue, body tissue, Body Tissues, Body tissue, NOS, body tissues, Tissues, Tissues, Tissues, Tissues\n",
      "Entity Name: tissues\n",
      "Concept_Id = C0391978 Score = 0.8561832904815674\n",
      "CUI: C0391978, Name: Bone Tissue\n",
      "Definition: The mineralized osseous tissue that gives rigidity to the bones and forms its honeycomb-like three-dimensional internal structure.\n",
      "TUI(s): T024\n",
      "Aliases (abbreviated, total: 27): \n",
      "\t Bone Tissue, Bone Tissue, Bone tissue, Bone tissue, bone tissue, bone tissue, Bone (tissue), bone tissues, Bone Tissues, Tissues, Bone\n",
      "Entity Name: blood sugar\n",
      "Concept_Id = C0005802 Score = 1.0\n",
      "CUI: C0005802, Name: Blood Glucose\n",
      "Definition: Glucose in blood.\n",
      "TUI(s): T109\n",
      "Aliases (abbreviated, total: 22): \n",
      "\t Blood Glucose, Blood Glucose, Blood Glucose, Blood Glucose, glucose blood, blood glucose, blood glucose, Glucose, Blood, Glucose, Blood, Blood Sugar\n",
      "Entity Name: blood sugar\n",
      "Concept_Id = C0392201 Score = 1.0\n",
      "CUI: C0392201, Name: Blood glucose measurement\n",
      "Definition: A quantitative measurement for assessing the amount of glucose present in a blood sample.\n",
      "TUI(s): T059\n",
      "Aliases (abbreviated, total: 25): \n",
      "\t Glucose measurement, blood, Glucose measurement, blood, Glucose, blood, measurement, Glucose Measurement, Blood, Blood Glucose Measurement, Blood Glucose Measurement, blood glucose measurement, blood glucose measurements, Blood Glucose, blood glucose\n",
      "Entity Name: brain\n",
      "Concept_Id = C0006104 Score = 1.0\n",
      "CUI: C0006104, Name: Brain\n",
      "Definition: The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 35): \n",
      "\t Brain, Brain, Brain, Brain, Brain, Brain, Brain, Brain, Brain, Brain\n",
      "Entity Name: brain\n",
      "Concept_Id = C0006121 Score = 0.8662683367729187\n",
      "CUI: C0006121, Name: Brain Stem\n",
      "Definition: The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.\n",
      "TUI(s): T023\n",
      "Aliases (abbreviated, total: 31): \n",
      "\t Brain Stem, Brain Stem, Brain Stem, Brain Stem, Brain Stem, Brain stem, Brain stem, Brain stem, Brain stem, Brain stem\n",
      "Entity Name: fat\n",
      "Concept_Id = C3272929 Score = 1.0\n",
      "CUI: C3272929, Name: Fat Measurement\n",
      "Definition: The determination of the amount of fat present in a sample.\n",
      "TUI(s): T059\n",
      "Aliases: (total: 4): \n",
      "\t Fat Measurement, Fat, Fat, FAT\n",
      "Entity Name: fat\n",
      "Concept_Id = C0015677 Score = 1.0\n",
      "CUI: C0015677, Name: Fatty acid glycerol esters\n",
      "Definition: The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet (DIETARY FATS) as a source of energy. (Grant & Hackh's Chemical Dictionary, 5th ed)\n",
      "TUI(s): T109, T121\n",
      "Aliases (abbreviated, total: 16): \n",
      "\t Fats, Fats, Fats, fats, Fat, Fat, Fat, Fat, Fat, FAT\n",
      "Entity Name: pancreatic β-cell\n",
      "Concept_Id = C0030280 Score = 0.7059562802314758\n",
      "CUI: C0030280, Name: Structure of alpha Cell of islet\n",
      "Definition: A cell in the periphery of the pancreatic islets that secretes glucagon.\n",
      "TUI(s): T025\n",
      "Aliases (abbreviated, total: 35): \n",
      "\t Structure of alpha Cell of islet, Pancreatic alpha Cells, pancreatic alpha cells, alpha Cell, Pancreatic, Pancreatic alpha Cell, pancreatic alpha cell, Pancreatic alpha cell, alpha Cells, Pancreatic, alpha Cell of islet, alpha Cell of islet\n",
      "Entity Name: GLP-1\n",
      "Concept_Id = C0061355 Score = 1.0\n",
      "CUI: C0061355, Name: Glucagon-Like Peptide 1\n",
      "Definition: A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.\n",
      "TUI(s): T116\n",
      "Aliases (abbreviated, total: 18): \n",
      "\t Glucagon-Like Peptide 1, Glucagon-Like Peptide 1, Glucagon-like peptide 1, Glucagon-like peptide 1, Glucagon-like peptide 1, glucagon like peptide 1, Glucagon Like Peptide 1, Glucagon-Like Peptide-1, Glucagon-Like Peptide-1, GLP-1\n",
      "Entity Name: GLP-1\n",
      "Concept_Id = C3539624 Score = 1.0\n",
      "CUI: C3539624, Name: GATA-Type Zinc Finger Protein 1\n",
      "Definition: GATA-type zinc finger protein 1 (271 aa, ~30 kDa) is encoded by the human ZGLP1 gene. This protein is involved in the inhibition of transcription by GATA family transcription factors.\n",
      "TUI(s): T116, T123\n",
      "Aliases: (total: 7): \n",
      "\t GATA-Type Zinc Finger Protein 1, GLP-1, Zinc Finger, GATA-Like Protein 1 Gene, GATA Like Protein 1, GATA Like Protein-1, GATA-Like Protein 1, ZGLP1\n",
      "Entity Name: leptin\n",
      "Concept_Id = C0299583 Score = 1.0\n",
      "CUI: C0299583, Name: leptin\n",
      "Definition: Leptin (167 aa, ~16 kDa) is encoded by the human LEP gene. This protein is secreted by adipocytes and plays a role in the regulation of both appetite and body fat stores.\n",
      "TUI(s): T116, T125\n",
      "Aliases (abbreviated, total: 26): \n",
      "\t leptin, leptin, leptin, Leptin, Leptin, Leptin, Leptin, Leptin, Leptin, Leptin\n",
      "Entity Name: leptin\n",
      "Concept_Id = C1295176 Score = 1.0\n",
      "CUI: C1295176, Name: Leptin measurement\n",
      "Definition: The determination of the amount of leptin hormone present in a sample.\n",
      "TUI(s): T059\n",
      "Aliases: (total: 6): \n",
      "\t Leptin measurement, Leptin Measurement, Leptin, Leptin, LEPTIN, Leptin measurement (procedure)\n",
      "Entity Name: adiponectin\n",
      "Concept_Id = C0389071 Score = 1.0\n",
      "CUI: C0389071, Name: Adiponectin\n",
      "Definition: A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.\n",
      "TUI(s): T116, T123\n",
      "Aliases (abbreviated, total: 21): \n",
      "\t Adiponectin, Adiponectin, Adiponectin, Adiponectin, Adiponectin, adiponectin, adiponectin, Adipocyte Complement-Related Protein 30-kDa, Adipocyte Complement-Related Protein 30-kDa, Adipocyte Complement Related Protein 30 kDa\n",
      "Entity Name: adiponectin\n",
      "Concept_Id = C2700366 Score = 1.0\n",
      "CUI: C2700366, Name: Adiponectin Measurement\n",
      "Definition: The determination of the amount of adiponectin hormone present in a sample.\n",
      "TUI(s): T059\n",
      "Aliases: (total: 4): \n",
      "\t Adiponectin Measurement, Adiponectin, Adiponectin, ADPNCTN\n",
      "Entity Name: glucagon\n",
      "Concept_Id = C0017687 Score = 1.0\n",
      "CUI: C0017687, Name: Glucagon\n",
      "Definition: A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases (abbreviated, total: 62): \n",
      "\t Glucagon, Glucagon, Glucagon, Glucagon, Glucagon, Glucagon, Glucagon, Glucagon, Glucagon, Glucagon\n",
      "Entity Name: glucagon\n",
      "Concept_Id = C0876232 Score = 1.0\n",
      "CUI: C0876232, Name: glucagon (rDNA)\n",
      "Definition: The recombinant form of the endogenous polypeptide hormone Glucagon consisting of 29 amino acids responsible for the release of stored glucose, causing increased blood glucose levels. Clinical Use: Diagnostic Aid for Imaging Studies and Hypoglycemia.\n",
      "TUI(s): T116, T121, T125\n",
      "Aliases: (total: 9): \n",
      "\t glucagon (rDNA), glucagon (rDNA), Glucagon, GLUCAGON, Hyperglycemic Glycogenolytic Factor, Antidiabetic Hormone, Glucagon (recombinant dna origin), Glucagon recombinant, Recombinant Glucagon\n",
      "Entity Name: tumour necrosis factor α\n",
      "Concept_Id = C0041368 Score = 1.0\n",
      "CUI: C0041368, Name: Tumor Necrosis Factors\n",
      "Definition: A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.\n",
      "TUI(s): T116, T129\n",
      "Aliases (abbreviated, total: 31): \n",
      "\t Tumor Necrosis Factors, Tumor Necrosis Factors, Tumor Necrosis Factors, Tumor Necrosis Factors, tumor necrosis factor, tumor necrosis factor, tumor necrosis factor, Tumor necrosis factor, tumour necrosis factor, Necrosis Factors, Tumor\n",
      "Entity Name: tumour necrosis factor α\n",
      "Concept_Id = C1456820 Score = 1.0\n",
      "CUI: C1456820, Name: Tumor Necrosis Factor-alpha\n",
      "Definition: Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.\n",
      "TUI(s): T116, T129\n",
      "Aliases (abbreviated, total: 44): \n",
      "\t Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-alpha, tumor necrosis factor alpha, tumor necrosis factor alpha, Tumor necrosis factor alpha, Tumor necrosis factor alpha, tumor necrosis factor-alpha, Tumor necrosis factor.alpha, Tumor necrosis factor.alpha, Tumor Necrosis Factor alpha\n",
      "Entity Name: Patients\n",
      "Concept_Id = C0030705 Score = 0.9999999403953552\n",
      "CUI: C0030705, Name: Patients\n",
      "Definition: Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.\n",
      "TUI(s): T101\n",
      "Aliases (abbreviated, total: 25): \n",
      "\t Patients, Patients, Patients, Patients, patients, Patient, Patient, Patient, Patient, Patient\n",
      "Entity Name: Patients\n",
      "Concept_Id = C0025360 Score = 0.8272134065628052\n",
      "CUI: C0025360, Name: Mentally Ill Persons\n",
      "Definition: Persons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.\n",
      "TUI(s): T101\n",
      "Aliases (abbreviated, total: 11): \n",
      "\t Mentally Ill Person, Person, Mentally Ill, Persons, Mentally Ill, Mental Patients, mental patients, mental patient, Mentally Ill, mentally ill, mentally ill, Mentally ill\n",
      "Entity Name: pancreatic α-cell\n",
      "Concept_Id = C0030280 Score = 0.70771723985672\n",
      "CUI: C0030280, Name: Structure of alpha Cell of islet\n",
      "Definition: A cell in the periphery of the pancreatic islets that secretes glucagon.\n",
      "TUI(s): T025\n",
      "Aliases (abbreviated, total: 35): \n",
      "\t Structure of alpha Cell of islet, Pancreatic alpha Cells, pancreatic alpha cells, alpha Cell, Pancreatic, Pancreatic alpha Cell, pancreatic alpha cell, Pancreatic alpha cell, alpha Cells, Pancreatic, alpha Cell of islet, alpha Cell of islet\n",
      "Entity Name: year[23\n",
      "Concept_Id = C0439234 Score = 0.8055164813995361\n",
      "CUI: C0439234, Name: year\n",
      "Definition: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.\n",
      "TUI(s): T079\n",
      "Aliases (abbreviated, total: 20): \n",
      "\t year, year, year, year, year, year, year, Year, Year, Year\n",
      "Entity Name: year[23\n",
      "Concept_Id = C1561543 Score = 0.8055164813995361\n",
      "CUI: C1561543, Name: Transaction counts and value totals - year\n",
      "Definition: <p>Transaction counts and value totals for each calendar year within the date range specified.</p>\n",
      "TUI(s): T170\n",
      "Aliases: (total: 1): \n",
      "\t year\n",
      "Entity Name: maternal\n",
      "Concept_Id = C1858460 Score = 1.0\n",
      "CUI: C1858460, Name: Maternal\n",
      "Definition: A designation that has some relationship to motherhood.\n",
      "TUI(s): T033\n",
      "Aliases: (total: 4): \n",
      "\t Maternal, Maternal, Maternal, maternal\n",
      "Entity Name: maternal\n",
      "Concept_Id = C0026591 Score = 1.0\n",
      "CUI: C0026591, Name: Mother (person)\n",
      "Definition: Female parents, human or animal.\n",
      "TUI(s): T099\n",
      "Aliases (abbreviated, total: 21): \n",
      "\t Mother (person), Maternal, Maternal, maternal, woman with children, Mothers, Mothers, Mothers, mothers, Mother\n",
      "Entity Name: fetal\n",
      "Concept_Id = C0015965 Score = 1.0\n",
      "CUI: C0015965, Name: Fetus\n",
      "Definition: The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.\n",
      "TUI(s): T018\n",
      "Aliases (abbreviated, total: 20): \n",
      "\t Fetus, Fetus, Fetus, Fetus, Fetus, Fetus, Fetus, Fetus, Fetus, Fetus\n",
      "Entity Name: fetal\n",
      "Concept_Id = C0033052 Score = 1.0\n",
      "CUI: C0033052, Name: Prenatal care\n",
      "Definition: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.\n",
      "TUI(s): T058\n",
      "Aliases (abbreviated, total: 21): \n",
      "\t Prenatal care, Prenatal care, Prenatal care, Care, Prenatal, Prenatal Care, Prenatal Care, prenatal care, prenatal care, prenatal care, Antepartum care of mother\n"
     ]
    }
   ],
   "source": [
    "unified_medical_language_entity_linker(en_ner_bionlp13cg_md,test_doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting swifter\n",
      "  Downloading swifter-1.0.7.tar.gz (633 kB)\n",
      "\u001b[K     |████████████████████████████████| 633 kB 1.5 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: pandas>=1.0.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (1.0.5)\n",
      "Requirement already satisfied: psutil>=5.6.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (5.7.0)\n",
      "Requirement already satisfied: dask[dataframe]>=2.10.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (2.20.0)\n",
      "Requirement already satisfied: tqdm>=4.33.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (4.47.0)\n",
      "Requirement already satisfied: ipywidgets>=7.0.0cloudpickle>=0.2.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (7.5.1)\n",
      "Requirement already satisfied: parso>0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (0.7.0)\n",
      "Requirement already satisfied: bleach>=3.1.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from swifter) (3.1.5)\n",
      "Collecting modin[ray]>=0.8.1.1\n",
      "  Downloading modin-0.8.1.1-py3-none-macosx_10_9_x86_64.whl (538 kB)\n",
      "\u001b[K     |████████████████████████████████| 538 kB 16.0 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: numpy>=1.13.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from pandas>=1.0.0->swifter) (1.19.2)\n",
      "Requirement already satisfied: python-dateutil>=2.6.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from pandas>=1.0.0->swifter) (2.8.1)\n",
      "Requirement already satisfied: pytz>=2017.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from pandas>=1.0.0->swifter) (2020.1)\n",
      "Requirement already satisfied: pyyaml in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from dask[dataframe]>=2.10.0->swifter) (5.3.1)\n",
      "Requirement already satisfied: fsspec>=0.6.0; extra == \"dataframe\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from dask[dataframe]>=2.10.0->swifter) (0.7.4)\n",
      "Requirement already satisfied: partd>=0.3.10; extra == \"dataframe\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from dask[dataframe]>=2.10.0->swifter) (1.1.0)\n",
      "Requirement already satisfied: toolz>=0.8.2; extra == \"dataframe\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from dask[dataframe]>=2.10.0->swifter) (0.10.0)\n",
      "Requirement already satisfied: widgetsnbextension~=3.5.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (3.5.1)\n",
      "Requirement already satisfied: nbformat>=4.2.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (5.0.7)\n",
      "Requirement already satisfied: ipython>=4.0.0; python_version >= \"3.3\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (7.16.1)\n",
      "Requirement already satisfied: ipykernel>=4.5.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (5.3.2)\n",
      "Requirement already satisfied: traitlets>=4.3.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (4.3.3)\n",
      "Requirement already satisfied: six>=1.9.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from bleach>=3.1.1->swifter) (1.12.0)\n",
      "Requirement already satisfied: packaging in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from bleach>=3.1.1->swifter) (20.4)\n",
      "Requirement already satisfied: webencodings in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from bleach>=3.1.1->swifter) (0.5.1)\n",
      "Collecting pyarrow<0.17; extra == \"ray\"\n",
      "  Downloading pyarrow-0.16.0-cp38-cp38-macosx_10_9_x86_64.whl (40.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 40.5 MB 14.7 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting ray>=1.0.0; extra == \"ray\"\n",
      "  Downloading ray-1.0.0-cp38-cp38-macosx_10_13_x86_64.whl (44.8 MB)\n",
      "\u001b[K     |████████████████████████████████| 44.8 MB 31.4 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: locket in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from partd>=0.3.10; extra == \"dataframe\"->dask[dataframe]>=2.10.0->swifter) (0.2.0)\n",
      "Requirement already satisfied: notebook>=4.4.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (6.0.3)\n",
      "Requirement already satisfied: jupyter-core in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbformat>=4.2.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (4.6.3)\n",
      "Requirement already satisfied: ipython-genutils in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbformat>=4.2.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.2.0)\n",
      "Requirement already satisfied: jsonschema!=2.5.0,>=2.4 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbformat>=4.2.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (3.2.0)\n",
      "Requirement already satisfied: decorator in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (4.4.2)\n",
      "Requirement already satisfied: jedi>=0.10 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.17.1)\n",
      "Requirement already satisfied: pickleshare in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.7.5)\n",
      "Requirement already satisfied: appnope; sys_platform == \"darwin\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.1.0)\n",
      "Requirement already satisfied: backcall in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.2.0)\n",
      "Requirement already satisfied: setuptools>=18.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (49.2.0.post20200714)\n",
      "Requirement already satisfied: prompt-toolkit!=3.0.0,!=3.0.1,<3.1.0,>=2.0.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (3.0.5)\n",
      "Requirement already satisfied: pexpect; sys_platform != \"win32\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (4.8.0)\n",
      "Requirement already satisfied: pygments in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (2.6.1)\n",
      "Requirement already satisfied: jupyter-client in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipykernel>=4.5.1->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (6.1.6)\n",
      "Requirement already satisfied: tornado>=4.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ipykernel>=4.5.1->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (6.0.4)\n",
      "Requirement already satisfied: pyparsing>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from packaging->bleach>=3.1.1->swifter) (2.4.7)\n",
      "Requirement already satisfied: colorama in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (0.4.3)\n",
      "Collecting py-spy>=0.2.0\n",
      "  Downloading py_spy-0.3.3-py2.py3-none-macosx_10_7_x86_64.whl (1.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 1.5 MB 7.7 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: requests in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (2.24.0)\n",
      "Requirement already satisfied: prometheus-client>=0.7.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (0.8.0)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting gpustat\n",
      "  Downloading gpustat-0.6.0.tar.gz (78 kB)\n",
      "\u001b[K     |████████████████████████████████| 78 kB 20.6 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: protobuf>=3.8.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (3.13.0)\n",
      "Requirement already satisfied: grpcio>=1.28.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (1.31.0)\n",
      "Collecting redis<3.5.0,>=3.3.2\n",
      "  Downloading redis-3.4.1-py2.py3-none-any.whl (71 kB)\n",
      "\u001b[K     |████████████████████████████████| 71 kB 25.7 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting google\n",
      "  Downloading google-3.0.0-py2.py3-none-any.whl (45 kB)\n",
      "\u001b[K     |████████████████████████████████| 45 kB 13.4 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting aioredis\n",
      "  Downloading aioredis-1.3.1-py3-none-any.whl (65 kB)\n",
      "\u001b[K     |████████████████████████████████| 65 kB 10.5 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting aiohttp\n",
      "  Downloading aiohttp-3.7.0-cp38-cp38-macosx_10_14_x86_64.whl (651 kB)\n",
      "\u001b[K     |████████████████████████████████| 651 kB 30.9 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting msgpack<2.0.0,>=1.0.0\n",
      "  Downloading msgpack-1.0.0-cp38-cp38-macosx_10_13_x86_64.whl (78 kB)\n",
      "\u001b[K     |████████████████████████████████| 78 kB 20.2 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: filelock in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (3.0.12)\n",
      "Requirement already satisfied: click>=7.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (7.1.2)\n",
      "Collecting aiohttp-cors\n",
      "  Downloading aiohttp_cors-0.7.0-py3-none-any.whl (27 kB)\n",
      "Collecting colorful\n",
      "  Downloading colorful-0.5.4-py2.py3-none-any.whl (201 kB)\n",
      "\u001b[K     |████████████████████████████████| 201 kB 30.7 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting opencensus\n",
      "  Downloading opencensus-0.7.11-py2.py3-none-any.whl (127 kB)\n",
      "\u001b[K     |████████████████████████████████| 127 kB 32.9 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: pyzmq>=17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (19.0.1)\n",
      "Requirement already satisfied: terminado>=0.8.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.8.3)\n",
      "Requirement already satisfied: jinja2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (2.11.2)\n",
      "Requirement already satisfied: Send2Trash in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (1.5.0)\n",
      "Requirement already satisfied: nbconvert in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (5.6.1)\n",
      "Requirement already satisfied: pyrsistent>=0.14.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from jsonschema!=2.5.0,>=2.4->nbformat>=4.2.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.16.0)\n",
      "Requirement already satisfied: attrs>=17.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from jsonschema!=2.5.0,>=2.4->nbformat>=4.2.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (19.3.0)\n",
      "Requirement already satisfied: wcwidth in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from prompt-toolkit!=3.0.0,!=3.0.1,<3.1.0,>=2.0.0->ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.2.5)\n",
      "Requirement already satisfied: ptyprocess>=0.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from pexpect; sys_platform != \"win32\"->ipython>=4.0.0; python_version >= \"3.3\"->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.6.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (2020.6.20)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (3.0.4)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (1.25.9)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (2.10)\n",
      "Collecting nvidia-ml-py3>=7.352.0\n",
      "  Downloading nvidia-ml-py3-7.352.0.tar.gz (19 kB)\n",
      "Collecting blessings>=1.6\n",
      "  Downloading blessings-1.7-py3-none-any.whl (18 kB)\n",
      "Requirement already satisfied: beautifulsoup4 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from google->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (4.8.0)\n",
      "Collecting async-timeout\n",
      "  Downloading async_timeout-3.0.1-py3-none-any.whl (8.2 kB)\n",
      "Collecting hiredis\n",
      "  Downloading hiredis-1.1.0-cp38-cp38-macosx_10_9_x86_64.whl (19 kB)\n",
      "Collecting yarl<2.0,>=1.0\n",
      "  Downloading yarl-1.6.2-cp38-cp38-macosx_10_14_x86_64.whl (127 kB)\n",
      "\u001b[K     |████████████████████████████████| 127 kB 31.3 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting multidict<7.0,>=4.5\n",
      "  Downloading multidict-5.0.0-cp38-cp38-macosx_10_14_x86_64.whl (48 kB)\n",
      "\u001b[K     |████████████████████████████████| 48 kB 22.6 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting google-api-core<2.0.0,>=1.0.0\n",
      "  Downloading google_api_core-1.23.0-py2.py3-none-any.whl (91 kB)\n",
      "\u001b[K     |████████████████████████████████| 91 kB 26.4 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting opencensus-context==0.1.2\n",
      "  Downloading opencensus_context-0.1.2-py2.py3-none-any.whl (4.4 kB)\n",
      "Requirement already satisfied: MarkupSafe>=0.23 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from jinja2->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (1.1.1)\n",
      "Requirement already satisfied: mistune<2,>=0.8.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbconvert->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.8.4)\n",
      "Requirement already satisfied: defusedxml in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbconvert->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.6.0)\n",
      "Requirement already satisfied: pandocfilters>=1.4.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbconvert->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (1.4.2)\n",
      "Requirement already satisfied: testpath in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbconvert->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.4.4)\n",
      "Requirement already satisfied: entrypoints>=0.2.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from nbconvert->notebook>=4.4.1->widgetsnbextension~=3.5.0->ipywidgets>=7.0.0cloudpickle>=0.2.2->swifter) (0.3)\n",
      "Requirement already satisfied: soupsieve>=1.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from beautifulsoup4->google->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (2.0.1)\n",
      "Collecting googleapis-common-protos<2.0dev,>=1.6.0\n",
      "  Downloading googleapis_common_protos-1.52.0-py2.py3-none-any.whl (100 kB)\n",
      "\u001b[K     |████████████████████████████████| 100 kB 34.3 MB/s ta 0:00:01\n",
      "\u001b[?25hCollecting google-auth<2.0dev,>=1.21.1\n",
      "  Downloading google_auth-1.22.1-py2.py3-none-any.whl (114 kB)\n",
      "\u001b[K     |████████████████████████████████| 114 kB 21.2 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: pyasn1-modules>=0.2.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from google-auth<2.0dev,>=1.21.1->google-api-core<2.0.0,>=1.0.0->opencensus->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (0.2.8)\n",
      "Requirement already satisfied: cachetools<5.0,>=2.0.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from google-auth<2.0dev,>=1.21.1->google-api-core<2.0.0,>=1.0.0->opencensus->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (4.1.1)\n",
      "Requirement already satisfied: rsa<5,>=3.1.4; python_version >= \"3.5\" in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from google-auth<2.0dev,>=1.21.1->google-api-core<2.0.0,>=1.0.0->opencensus->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (4.5)\n",
      "Requirement already satisfied: pyasn1<0.5.0,>=0.4.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from pyasn1-modules>=0.2.1->google-auth<2.0dev,>=1.21.1->google-api-core<2.0.0,>=1.0.0->opencensus->ray>=1.0.0; extra == \"ray\"->modin[ray]>=0.8.1.1->swifter) (0.4.8)\n",
      "Building wheels for collected packages: swifter, gpustat, nvidia-ml-py3\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  Building wheel for swifter (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for swifter: filename=swifter-1.0.7-py3-none-any.whl size=13977 sha256=d4e43e85b981d3d8f3d7c7e9a8060078601b8e2dd7a8936b9555874540952afb\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/cc/a3/ca/87533bb1e618d962a03e9286da38e9e21b1d135848f1112bda\n",
      "  Building wheel for gpustat (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for gpustat: filename=gpustat-0.6.0-py3-none-any.whl size=12617 sha256=cade4511b0b89d6b50048786b4e5d6ecb473bd8032428b86cfdda531a03331c8\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/0d/d9/80/b6cbcdc9946c7b50ce35441cc9e7d8c5a9d066469ba99bae44\n",
      "  Building wheel for nvidia-ml-py3 (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for nvidia-ml-py3: filename=nvidia_ml_py3-7.352.0-py3-none-any.whl size=19189 sha256=ef88bb31e719d1d6807995233b0866bdbab25b4465600a85c18ab5ebb61a7aa4\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/b9/b1/68/cb4feab29709d4155310d29a421389665dcab9eb3b679b527b\n",
      "Successfully built swifter gpustat nvidia-ml-py3\n",
      "\u001b[31mERROR: medacy 1.0.0 has requirement msgpack<0.6,>=0.3.0, but you'll have msgpack 1.0.0 which is incompatible.\u001b[0m\n",
      "\u001b[31mERROR: medacy 1.0.0 has requirement transformers==2.3.0, but you'll have transformers 3.0.2 which is incompatible.\u001b[0m\n",
      "\u001b[31mERROR: google-api-core 1.23.0 has requirement six>=1.13.0, but you'll have six 1.12.0 which is incompatible.\u001b[0m\n",
      "\u001b[31mERROR: modin 0.8.1.1 has requirement pandas==1.1.2, but you'll have pandas 1.0.5 which is incompatible.\u001b[0m\n",
      "Installing collected packages: pyarrow, py-spy, nvidia-ml-py3, blessings, gpustat, redis, google, async-timeout, hiredis, aioredis, multidict, yarl, aiohttp, msgpack, aiohttp-cors, colorful, googleapis-common-protos, google-auth, google-api-core, opencensus-context, opencensus, ray, modin, swifter\n",
      "  Attempting uninstall: pyarrow\n",
      "    Found existing installation: pyarrow 2.0.0\n",
      "    Uninstalling pyarrow-2.0.0:\n",
      "      Successfully uninstalled pyarrow-2.0.0\n",
      "  Attempting uninstall: msgpack\n",
      "    Found existing installation: msgpack 0.5.6\n",
      "    Uninstalling msgpack-0.5.6:\n",
      "      Successfully uninstalled msgpack-0.5.6\n",
      "  Attempting uninstall: google-auth\n",
      "    Found existing installation: google-auth 1.21.0\n",
      "    Uninstalling google-auth-1.21.0:\n",
      "      Successfully uninstalled google-auth-1.21.0\n",
      "Successfully installed aiohttp-3.7.0 aiohttp-cors-0.7.0 aioredis-1.3.1 async-timeout-3.0.1 blessings-1.7 colorful-0.5.4 google-3.0.0 google-api-core-1.23.0 google-auth-1.22.1 googleapis-common-protos-1.52.0 gpustat-0.6.0 hiredis-1.1.0 modin-0.8.1.1 msgpack-1.0.0 multidict-5.0.0 nvidia-ml-py3-7.352.0 opencensus-0.7.11 opencensus-context-0.1.2 py-spy-0.3.3 pyarrow-0.16.0 ray-1.0.0 redis-3.4.1 swifter-1.0.7 yarl-1.6.2\n"
     ]
    }
   ],
   "source": [
    "!pip install swifter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "import scispacy\n",
    "import swifter\n",
    "import pandas as pd\n",
    "from spacy import displacy\n",
    "import en_core_sci_sm\n",
    "#import en_core_sci_md\n",
    "# import en_ner_bc5cdr_md\n",
    "# import en_ner_jnlpba_md\n",
    "# import en_ner_craft_md\n",
    "# import en_ner_bionlp13cg_md\n",
    "from scispacy.abbreviation import AbbreviationDetector\n",
    "from collections import OrderedDict,Counter\n",
    "from pprint import pprint\n",
    "from tqdm import tqdm\n",
    "tqdm.pandas()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "sample_text= \"\"\"CORONAVIRUS RESEARCH: KEYS TO DIAGNOSIS, TREATMENT, AND PREVENTION OF SARS\n",
    "Mark R. Denison, M.D.\n",
    "For coronavirus investigators, the recognition of a new coronavirus as the cause of severe acute respiratory syndrome (SARS) was certainly remarkable, yet perhaps not surprising (Baric et al., 1995). The cadre of investigators who have worked with this intriguing family of viruses over the past 30 years are familiar with many of the features of coronavirus biology, pathogenesis, and disease that manifested so dramatically in the worldwide SARS epidemic. Advances in the biology of coronaviruses have resulted in greater understanding of their capacity for adaptation to new environments, transspecies infection, and emergence of new diseases. New tools of cell and molecular biology have led to increased understanding of intracellular replication and viral cell biology, and the advent in the past five years of reverse genetic approaches to study coronaviruses has made it possible to begin to define the determinants of viral replication, transpecies adaptation, and human disease. This summary will discuss the basic life cycle and replication of the well-studied coronavirus, mouse hepatitis virus (MHV), identifying the unique characteristics of coronavirus biology and highlighting critical points where research has made significant advances, and which might represent targets for antivirals or vaccines. Areas where rapid progress has been made in SCoV research will be described. Finally, areas of need for research in coronavirus replication, genetics, and pathogenesis will be summarized.\n",
    "Coronavirus Life Cycle\n",
    "The best studied model for coronavirus replication and pathogenesis has been the group 2 murine coronavirus, mouse hepatitis virus, and much of what is known of the stages of the coronavirus life cycle has been determined in animals and in culture using this virus. Thus this discussion will focus on MHV with comparisons to SCoV and other coronaviruses. This is appropriate because bioinformatics analyses suggest that SCoV, while a distinct virus, has significant similarities in organization, putative protein functions, and replication to the group II coronaviruses, particularly within the replicase gene (Snijder et al., 2003). Excellent, detailed reviews of MHV and coronavirus replication are available elsewhere (Holmes and Lai, 1996; Lai and Cavanagh, 1997).\n",
    "The coronavirus virion is an enveloped particle containing the spike (S), membrane (M), and envelope (E) proteins. In addition, some strains of coronaviruses, but not SCoV, express a hemagglutinin protein (HE) that is also incorporated in the virion. The genome of coronaviruses is a linear, single-stranded RNA molecule of positive (mRNA) polarity, and from 28 to 32 kb in length (Bonilla et al., 1994; Drosten et al., 2003; Lee et al., 1991). Within the virion, the genome is encapsidated by multiple copies of the nucleocapsid protein (N), and has the conformation of a helical RNA/nucleocapsid structure. The S protein has been a focus of pathogenesis studies in mice because it appears to be the critical determinant of cell tropism, species specificity, host selection, cell tropism, and disease (Navas and Weiss, 2003; Navas et al., 2001; Rao and Gallagher, 1998).\n",
    "Virus replication is initiated by binding of the S protein to specific receptors on the host cell surface. For MHV, the primary receptor has been shown to be the carcino-embryonic antigen–cell adhesion molecule (CEACAM) (Dveksler et al., 1991; 1996; Holmes and Lai, 1996; Yokomuri and Lai, 1992), and for the human coronavirus, HCoV-229E, and other group 1 coronaviruses, the receptor is aminopeptidase N (Yeager et al., 1992). The precise mechanisms of entry and uncoating have yet to be defined, but likely occur by either fusion from without or viroplexis through endocytic vesicles. For wildtype MHV, entry and uncoating constitute a pH independent process that is probably direct fusion mediated by a fusion peptide in the S protein (Gallagher et al., 1991). The understanding of the region of the S1 component of coronavirus that binds to receptors was the basis for studies leading to the very recent and very rapid identification of angiotensin converting enzyme 2 (ACE 2) as a receptor for SCoV (Li et al., 2003).\n",
    "The next discrete stage in the life cycle is translation and proteolytic processing of viral replicase proteins from the input genome RNA, followed by formation of cytoplasmic replication complexes in association with cellular membranes (Denison et al., 1999; Gosert et al., 2002; Shi et al., 1999; van der Meer et al., 1999). Replication complexes are thought to be sites of all stages of viral RNA transcription and replication, and possibly assembly of nascent viral nucleocapsids. Viral assembly occurs both temporally and physically distinct from viral replication complexes in the endoplasmic-reticulum-Golgi-intermediate compartment (ERGIC), a transitional zone between late ER and Golgi (deVries et al., 1997; Klumperman et al., 1994; Krijnse-Locker et al., 1994; Rottier and Rose, 1987). Although the mechanisms by which replication products are delivered to sites of assembly remain to be determined, it has been shown that subpopulations of replicase proteins and the structural nucleocapsid (N) translocate from replication complexes to sites of assembly and may mediate the process in association with cellular membrane/protein trafficking pathways (Bost et al., 2000). Virus assembly in the ERGIC involves interactions of genome RNA, N, the membrane protein (M), and the small membrane protein (E), resulting in budding of virions into the lumen of ER/Golgi virosomes (Opstetten et al., 1995). Further maturation of virus particles occurs during movement through the Golgi, resulting in virosomes filled with mature particles (Salamuera et al., 1999). Trafficking of the virosomes to the cell surface has not been well characterized, but is presumed to occur via normal vesicle maturation and exocytic processes. The outcome is the nonlytic release of the vast majority of mature virions into the extracellular space. For MHV and several other coronaviruses that can directly fuse with cells, there is a characteristic and rapidly detectable cytopathic effect of cell-cell fusion into multinucleated syncytia. Production of infectious virus continues even after the majority of cells are fused. Syncytia were recently reported as a readout of SCoV receptor expression and cell infection (Li et al., 2003).\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "def display_entities(model,document):\n",
    "    \"\"\" A function that returns a tuple of displacy image of named or unnamed word entities and\n",
    "        a set of unique entities recognized based on scispacy model in use\n",
    "        Args: \n",
    "            model: A pretrained model from spaCy or ScispaCy\n",
    "            document: text data to be analysed\"\"\"\n",
    "    nlp = model.load()\n",
    "    doc = nlp(document)\n",
    "    displacy_image = displacy.render(doc, jupyter=True,style='ent')\n",
    "    entity_and_label = set([(X.text, X.label_) for X in doc.ents])\n",
    "    return  displacy_image, entity_and_label"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">CORONAVIRUS RESEARCH: KEYS TO DIAGNOSIS, TREATMENT, AND PREVENTION OF \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "</br>Mark R. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Denison\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", M.D.</br>For coronavirus investigators, the recognition of a new coronavirus as the cause of severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute respiratory syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") was certainly remarkable, yet perhaps not surprising (Baric et al., 1995). The cadre of investigators who have worked with this intriguing family of viruses over the past 30 years are familiar with many of the features of coronavirus biology, pathogenesis, and disease that manifested so dramatically in the worldwide \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " epidemic. Advances in the biology of coronaviruses have resulted in greater understanding of their capacity for adaptation to new environments, transspecies \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and emergence of new diseases. New tools of cell and molecular biology have led to increased understanding of intracellular replication and viral cell biology, and the advent in the past five years of reverse genetic approaches to study coronaviruses has made it possible to begin to define the determinants of viral replication, transpecies adaptation, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This summary will discuss the basic life cycle and replication of the well-studied coronavirus, mouse \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " virus (MHV), identifying the unique characteristics of coronavirus biology and highlighting critical points where research has made significant advances, and which might represent targets for antivirals or vaccines. Areas where rapid progress has been made in SCoV research will be described. Finally, areas of need for research in coronavirus replication, genetics, and pathogenesis will be summarized.</br>Coronavirus Life Cycle</br>The best studied model for coronavirus replication and pathogenesis has been the group 2 murine coronavirus, mouse \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " virus, and much of what is known of the stages of the coronavirus life cycle has been determined in animals and in culture using this virus. Thus this discussion will focus on MHV with comparisons to SCoV and other coronaviruses. This is appropriate because bioinformatics analyses suggest that SCoV, while a distinct virus, has significant similarities in organization, putative protein functions, and replication to the group II coronaviruses, particularly within the replicase gene (Snijder et al., 2003). Excellent, detailed reviews of MHV and coronavirus replication are available elsewhere (Holmes and Lai, 1996; Lai and Cavanagh, 1997).</br>The coronavirus virion is an enveloped particle containing the spike (S), membrane (M), and envelope (E) proteins. In addition, some strains of coronaviruses, but not SCoV, express a hemagglutinin protein (HE) that is also incorporated in the virion. The genome of coronaviruses is a linear, single-stranded RNA molecule of positive (mRNA) polarity, and from 28 to 32 kb in length (Bonilla et al., 1994; Drosten et al., 2003; Lee et al., 1991). Within the virion, the genome is encapsidated by multiple copies of the nucleocapsid protein (N), and has the conformation of a helical RNA/nucleocapsid structure. The S protein has been a focus of pathogenesis studies in mice because it appears to be the critical determinant of cell tropism, species specificity, host selection, cell tropism, and disease (Navas and Weiss, 2003; Navas et al., 2001; Rao and Gallagher, 1998).</br>Virus replication is initiated by binding of the S protein to specific receptors on the host cell surface. For MHV, the primary receptor has been shown to be the carcino-embryonic antigen–cell adhesion molecule (CEACAM) (Dveksler et al., 1991; 1996; Holmes and Lai, 1996; Yokomuri and Lai, 1992), and for the human coronavirus, HCoV-229E, and other group 1 coronaviruses, the receptor is aminopeptidase N (Yeager et al., 1992). The precise mechanisms of entry and uncoating have yet to be defined, but likely occur by either fusion from without or viroplexis through endocytic vesicles. For wildtype MHV, entry and uncoating constitute a pH independent process that is probably direct fusion mediated by a fusion peptide in the S protein (Gallagher et al., 1991). The understanding of the region of the S1 component of coronavirus that binds to receptors was the basis for studies leading to the very recent and very rapid identification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " converting enzyme 2 (ACE 2) as a receptor for SCoV (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Li\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " et al., 2003).</br>The next discrete stage in the life cycle is translation and proteolytic processing of viral replicase proteins from the input genome RNA, followed by formation of cytoplasmic replication complexes in association with cellular membranes (Denison et al., 1999; Gosert et al., 2002; Shi et al., 1999; van der Meer et al., 1999). Replication complexes are thought to be sites of all stages of viral RNA transcription and replication, and possibly assembly of nascent viral nucleocapsids. Viral assembly occurs both temporally and physically distinct from viral replication complexes in the endoplasmic-reticulum-Golgi-intermediate compartment (ERGIC), a transitional zone between late ER and Golgi (deVries et al., 1997; Klumperman et al., 1994; Krijnse-Locker et al., 1994; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rottier\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Rose, 1987). Although the mechanisms by which replication products are delivered to sites of assembly remain to be determined, it has been shown that subpopulations of replicase proteins and the structural nucleocapsid (N) translocate from replication complexes to sites of assembly and may mediate the process in association with cellular membrane/protein trafficking pathways (Bost et al., 2000). Virus assembly in the ERGIC involves interactions of genome RNA, N, the membrane protein (M), and the small membrane protein (E), resulting in budding of virions into the lumen of ER/Golgi virosomes (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Opstetten\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " et al., 1995). Further maturation of virus particles occurs during movement through the Golgi, resulting in virosomes filled with mature particles (Salamuera et al., 1999). Trafficking of the virosomes to the cell surface has not been well characterized, but is presumed to occur via normal vesicle maturation and exocytic processes. The outcome is the nonlytic release of the vast majority of mature virions into the extracellular space. For MHV and several other coronaviruses that can directly fuse with cells, there is a characteristic and rapidly detectable cytopathic effect of cell-cell fusion into multinucleated syncytia. Production of infectious virus continues even after the majority of cells are fused. Syncytia were recently reported as a readout of SCoV receptor expression and cell \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Li\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " et al., 2003).</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bc5dr_entities = display_entities(en_ner_bc5cdr_md,sample_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entity</th>\n",
       "      <th>Label</th>\n",
       "      <th>Ner_model</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>acute respiratory syndrome</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>SARS</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>hepatitis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>infection</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Opstetten</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Li</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Rottier</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>human disease</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>angiotensin</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Denison</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       Entity     Label Ner_model\n",
       "0  acute respiratory syndrome   DISEASE     bc5dr\n",
       "1                        SARS   DISEASE     bc5dr\n",
       "2                   hepatitis   DISEASE     bc5dr\n",
       "3                   infection   DISEASE     bc5dr\n",
       "4                   Opstetten  CHEMICAL     bc5dr\n",
       "5                          Li  CHEMICAL     bc5dr\n",
       "6                     Rottier  CHEMICAL     bc5dr\n",
       "7               human disease   DISEASE     bc5dr\n",
       "8                 angiotensin  CHEMICAL     bc5dr\n",
       "9                     Denison   DISEASE     bc5dr"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bc5dr_entities_dataframe = pd.DataFrame(bc5dr_entities[1],columns=['Entity','Label'])  #save returned values of entities and their labels in a pandas dataframe\n",
    "bc5dr_entities_dataframe['Ner_model'] = 'bc5dr'  #include a column with constant value of NER model\n",
    "bc5dr_entities_dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">CORONAVIRUS RESEARCH: KEYS TO \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DIAGNOSIS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TREATMENT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ", AND PREVENTION OF SARS</br>Mark R. Denison, M.D.</br>For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " investigators, the recognition of a new \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " as the cause of severe acute respiratory syndrome (SARS) was certainly remarkable, yet perhaps not surprising (Baric et al., 1995). The cadre of investigators who have worked with this intriguing family of viruses over the past 30 years are familiar with many of the features of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " biology, pathogenesis, and disease that manifested so dramatically in the worldwide SARS epidemic. Advances in the biology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " have resulted in greater understanding of their capacity for adaptation to new environments, transspecies infection, and emergence of new diseases. New tools of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " and molecular biology have led to increased understanding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intracellular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">IMMATERIAL_ANATOMICAL_ENTITY</span>\n",
       "</mark>\n",
       " replication and viral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " biology, and the advent in the past five years of reverse genetic approaches to study \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " has made it possible to begin to define the determinants of viral replication, transpecies adaptation, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " disease. This summary will discuss the basic life cycle and replication of the well-studied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse hepatitis virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       "), identifying the unique characteristics of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " biology and highlighting critical points where research has made significant advances, and which might represent targets for antivirals or vaccines. Areas where rapid progress has been made in SCoV research will be described. Finally, areas of need for research in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " replication, genetics, and pathogenesis will be summarized.</br>Coronavirus Life Cycle</br>The best studied model for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " replication and pathogenesis has been the group 2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    murine coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " hepatitis virus, and much of what is known of the stages of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " life cycle has been determined in animals and in culture using this virus. Thus this discussion will focus on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " with comparisons to SCoV and other coronaviruses. This is appropriate because bioinformatics analyses suggest that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", while a distinct virus, has significant similarities in organization, putative protein functions, and replication to the group II coronaviruses, particularly within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replicase\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " gene (Snijder et al., 2003). Excellent, detailed reviews of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " replication are available elsewhere (Holmes and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lai\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", 1996; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lai\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cavanagh\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       ", 1997).</br>The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " virion is an enveloped particle containing the spike (S), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " (M), and envelope (E) proteins. In addition, some strains of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", but not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", express a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemagglutinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " protein (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ") that is also incorporated in the virion. The genome of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " is a linear, single-stranded RNA molecule of positive (mRNA) polarity, and from 28 to 32 kb in length (Bonilla et al., 1994; Drosten et al., 2003; Lee et al., 1991). Within the virion, the genome is encapsidated by multiple copies of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleocapsid protein (N\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "), and has the conformation of a helical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RNA/nucleocapsid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CANCER</span>\n",
       "</mark>\n",
       " structure. The S protein has been a focus of pathogenesis studies in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " because it appears to be the critical determinant of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " tropism, species specificity, host selection, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " tropism, and disease (Navas and Weiss, 2003; Navas et al., 2001; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rao\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gallagher\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", 1998).</br>Virus replication is initiated by binding of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " protein to specific receptors on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    host cell surface\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       ". For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", the primary receptor has been shown to be the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcino-embryonic antigen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       "–cell adhesion molecule (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEACAM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ") (Dveksler et al., 1991; 1996; Holmes and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lai\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", 1996; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Yokomuri\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lai, 1992)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ", and for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HCoV-229E\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", and other group 1 coronaviruses, the receptor is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aminopeptidase N\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " (Yeager et al., 1992). The precise mechanisms of entry and uncoating have yet to be defined, but likely occur by either fusion from without or viroplexis through endocytic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vesicles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       ". For wildtype \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", entry and uncoating constitute a pH independent process that is probably direct fusion mediated by a fusion peptide in the S protein (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gallagher\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " et al., 1991). The understanding of the region of the S1 component of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " that binds to receptors was the basis for studies leading to the very recent and very rapid identification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin converting enzyme 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       ") as a receptor for SCoV (Li et al., 2003).</br>The next discrete stage in the life cycle is translation and proteolytic processing of viral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replicase\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " proteins from the input genome RNA, followed by formation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytoplasmic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " replication complexes in association with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cellular membranes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " (Denison et al., 1999; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gosert\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " et al., 2002; Shi et al., 1999; van der Meer et al., 1999). Replication complexes are thought to be sites of all stages of viral RNA transcription and replication, and possibly assembly of nascent viral nucleocapsids. Viral assembly occurs both temporally and physically distinct from viral replication complexes in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endoplasmic-reticulum-Golgi-intermediate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " compartment (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERGIC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SIMPLE_CHEMICAL</span>\n",
       "</mark>\n",
       "), a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    transitional zone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    late ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Golgi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " (deVries et al., 1997; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Klumperman\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " et al., 1994; Krijnse-Locker et al., 1994; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rottier\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " and Rose, 1987). Although the mechanisms by which replication products are delivered to sites of assembly remain to be determined, it has been shown that subpopulations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replicase\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " proteins and the structural \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleocapsid (N)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " translocate from replication complexes to sites of assembly and may mediate the process in association with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cellular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " membrane/protein trafficking pathways (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bost\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " et al., 2000). Virus assembly in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERGIC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " involves interactions of genome RNA, N, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " protein (M), and the small \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " protein (E), resulting in budding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lumen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM_SUBSTANCE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER/Golgi virosomes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " (Opstetten et al., 1995). Further maturation of virus particles occurs during movement through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Golgi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       ", resulting in virosomes filled with mature particles (Salamuera et al., 1999). Trafficking of the virosomes to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell surface\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       " has not been well characterized, but is presumed to occur via normal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vesicle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">IMMATERIAL_ANATOMICAL_ENTITY</span>\n",
       "</mark>\n",
       " maturation and exocytic processes. The outcome is the nonlytic release of the vast majority of mature \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    extracellular space\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELLULAR_COMPONENT</span>\n",
       "</mark>\n",
       ". For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " and several other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " that can directly fuse with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       ", there is a characteristic and rapidly detectable cytopathic effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " fusion into multinucleated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncytia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       ". Production of infectious virus continues even after the majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " are fused. Syncytia were recently reported as a readout of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GENE_OR_GENE_PRODUCT</span>\n",
       "</mark>\n",
       " expression and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " infection (Li et al., 2003).</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bionlp13cg_entities = display_entities(en_ner_bionlp13cg_md,sample_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entity</th>\n",
       "      <th>Label</th>\n",
       "      <th>Ner_model</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>cell</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>S</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>host cell surface</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ACE 2</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Cavanagh</td>\n",
       "      <td>SIMPLE_CHEMICAL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>lumen</td>\n",
       "      <td>ORGANISM_SUBSTANCE</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>vesicles</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Yokomuri</td>\n",
       "      <td>SIMPLE_CHEMICAL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>cell surface</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Lai, 1992)</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>ERGIC</td>\n",
       "      <td>SIMPLE_CHEMICAL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Gosert</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>vesicle</td>\n",
       "      <td>IMMATERIAL_ANATOMICAL_ENTITY</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>HE</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>cytoplasmic</td>\n",
       "      <td>ORGANISM_SUBSTANCE</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>syncytia</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>replicase</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Gallagher</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>endoplasmic-reticulum-Golgi-intermediate</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>SIMPLE_CHEMICAL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>late ER</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>angiotensin converting enzyme 2</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>RNA/nucleocapsid</td>\n",
       "      <td>CANCER</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>SCoV</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Rottier</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>coronavirus</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>murine coronavirus</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>carcino-embryonic antigen</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>nucleocapsid protein (N</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>cellular membranes</td>\n",
       "      <td>TISSUE</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>cell-cell</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>mice</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>virions</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>human coronavirus</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>DIAGNOSIS</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>membrane</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>ER/Golgi virosomes</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>cellular</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>coronaviruses</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>mouse</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>hemagglutinin</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Klumperman</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>mouse hepatitis virus</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>intracellular</td>\n",
       "      <td>IMMATERIAL_ANATOMICAL_ENTITY</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>transitional zone</td>\n",
       "      <td>TISSUE</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>aminopeptidase N</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>nucleocapsid (N)</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>extracellular space</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Lai</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>human</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Lai</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Rao</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>MHV</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Bost</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>HCoV-229E</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>SCoV receptor</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Golgi</td>\n",
       "      <td>CELLULAR_COMPONENT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>CEACAM</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>cells</td>\n",
       "      <td>CELL</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>ERGIC</td>\n",
       "      <td>GENE_OR_GENE_PRODUCT</td>\n",
       "      <td>bionlp13cg</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      Entity                         Label  \\\n",
       "0                                       cell                          CELL   \n",
       "1                                          S          GENE_OR_GENE_PRODUCT   \n",
       "2                          host cell surface                          CELL   \n",
       "3                                      ACE 2          GENE_OR_GENE_PRODUCT   \n",
       "4                                   Cavanagh               SIMPLE_CHEMICAL   \n",
       "5                                      lumen            ORGANISM_SUBSTANCE   \n",
       "6                                   vesicles            CELLULAR_COMPONENT   \n",
       "7                                   Yokomuri               SIMPLE_CHEMICAL   \n",
       "8                               cell surface            CELLULAR_COMPONENT   \n",
       "9                                 Lai, 1992)          GENE_OR_GENE_PRODUCT   \n",
       "10                                     ERGIC               SIMPLE_CHEMICAL   \n",
       "11                                    Gosert          GENE_OR_GENE_PRODUCT   \n",
       "12                                   vesicle  IMMATERIAL_ANATOMICAL_ENTITY   \n",
       "13                                        HE          GENE_OR_GENE_PRODUCT   \n",
       "14                               cytoplasmic            ORGANISM_SUBSTANCE   \n",
       "15                                  syncytia                          CELL   \n",
       "16                                 replicase          GENE_OR_GENE_PRODUCT   \n",
       "17                                 Gallagher          GENE_OR_GENE_PRODUCT   \n",
       "18  endoplasmic-reticulum-Golgi-intermediate          GENE_OR_GENE_PRODUCT   \n",
       "19                                 TREATMENT               SIMPLE_CHEMICAL   \n",
       "20                                   late ER            CELLULAR_COMPONENT   \n",
       "21           angiotensin converting enzyme 2          GENE_OR_GENE_PRODUCT   \n",
       "22                          RNA/nucleocapsid                        CANCER   \n",
       "23                                      SCoV          GENE_OR_GENE_PRODUCT   \n",
       "24                                   Rottier                          CELL   \n",
       "25                               coronavirus                      ORGANISM   \n",
       "26                        murine coronavirus                      ORGANISM   \n",
       "27                 carcino-embryonic antigen          GENE_OR_GENE_PRODUCT   \n",
       "28                   nucleocapsid protein (N          GENE_OR_GENE_PRODUCT   \n",
       "29                        cellular membranes                        TISSUE   \n",
       "30                                 cell-cell                          CELL   \n",
       "31                                      mice                      ORGANISM   \n",
       "32                                   virions                      ORGANISM   \n",
       "33                         human coronavirus                      ORGANISM   \n",
       "34                                 DIAGNOSIS          GENE_OR_GENE_PRODUCT   \n",
       "35                                  membrane            CELLULAR_COMPONENT   \n",
       "36                        ER/Golgi virosomes                      ORGANISM   \n",
       "37                                  cellular                          CELL   \n",
       "38                             coronaviruses                      ORGANISM   \n",
       "39                                     mouse                      ORGANISM   \n",
       "40                             hemagglutinin          GENE_OR_GENE_PRODUCT   \n",
       "41                                Klumperman                      ORGANISM   \n",
       "42                     mouse hepatitis virus                      ORGANISM   \n",
       "43                             intracellular  IMMATERIAL_ANATOMICAL_ENTITY   \n",
       "44                         transitional zone                        TISSUE   \n",
       "45                          aminopeptidase N          GENE_OR_GENE_PRODUCT   \n",
       "46                          nucleocapsid (N)          GENE_OR_GENE_PRODUCT   \n",
       "47                       extracellular space            CELLULAR_COMPONENT   \n",
       "48                                       Lai                      ORGANISM   \n",
       "49                                     human                      ORGANISM   \n",
       "50                                       Lai          GENE_OR_GENE_PRODUCT   \n",
       "51                                       Rao                          CELL   \n",
       "52                                       MHV                      ORGANISM   \n",
       "53                                      Bost          GENE_OR_GENE_PRODUCT   \n",
       "54                                 HCoV-229E                      ORGANISM   \n",
       "55                             SCoV receptor          GENE_OR_GENE_PRODUCT   \n",
       "56                                     Golgi            CELLULAR_COMPONENT   \n",
       "57                                    CEACAM          GENE_OR_GENE_PRODUCT   \n",
       "58                                     cells                          CELL   \n",
       "59                                     ERGIC          GENE_OR_GENE_PRODUCT   \n",
       "\n",
       "     Ner_model  \n",
       "0   bionlp13cg  \n",
       "1   bionlp13cg  \n",
       "2   bionlp13cg  \n",
       "3   bionlp13cg  \n",
       "4   bionlp13cg  \n",
       "5   bionlp13cg  \n",
       "6   bionlp13cg  \n",
       "7   bionlp13cg  \n",
       "8   bionlp13cg  \n",
       "9   bionlp13cg  \n",
       "10  bionlp13cg  \n",
       "11  bionlp13cg  \n",
       "12  bionlp13cg  \n",
       "13  bionlp13cg  \n",
       "14  bionlp13cg  \n",
       "15  bionlp13cg  \n",
       "16  bionlp13cg  \n",
       "17  bionlp13cg  \n",
       "18  bionlp13cg  \n",
       "19  bionlp13cg  \n",
       "20  bionlp13cg  \n",
       "21  bionlp13cg  \n",
       "22  bionlp13cg  \n",
       "23  bionlp13cg  \n",
       "24  bionlp13cg  \n",
       "25  bionlp13cg  \n",
       "26  bionlp13cg  \n",
       "27  bionlp13cg  \n",
       "28  bionlp13cg  \n",
       "29  bionlp13cg  \n",
       "30  bionlp13cg  \n",
       "31  bionlp13cg  \n",
       "32  bionlp13cg  \n",
       "33  bionlp13cg  \n",
       "34  bionlp13cg  \n",
       "35  bionlp13cg  \n",
       "36  bionlp13cg  \n",
       "37  bionlp13cg  \n",
       "38  bionlp13cg  \n",
       "39  bionlp13cg  \n",
       "40  bionlp13cg  \n",
       "41  bionlp13cg  \n",
       "42  bionlp13cg  \n",
       "43  bionlp13cg  \n",
       "44  bionlp13cg  \n",
       "45  bionlp13cg  \n",
       "46  bionlp13cg  \n",
       "47  bionlp13cg  \n",
       "48  bionlp13cg  \n",
       "49  bionlp13cg  \n",
       "50  bionlp13cg  \n",
       "51  bionlp13cg  \n",
       "52  bionlp13cg  \n",
       "53  bionlp13cg  \n",
       "54  bionlp13cg  \n",
       "55  bionlp13cg  \n",
       "56  bionlp13cg  \n",
       "57  bionlp13cg  \n",
       "58  bionlp13cg  \n",
       "59  bionlp13cg  "
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bionlp13cg_entities_dataframe = pd.DataFrame(bionlp13cg_entities[1],columns=['Entity','Label']) #save returned values of entities and their labels in a pandas dataframe\n",
    "bionlp13cg_entities_dataframe['Ner_model'] = 'bionlp13cg'  #include a column with constant value of NER model\n",
    "bionlp13cg_entities_dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_craft_md-0.2.0.tar.gz\n",
      "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_craft_md-0.2.0.tar.gz (82.1 MB)\n",
      "\u001b[K     |████████████████████████████████| 82.1 MB 2.4 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.1.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en-ner-craft-md==0.2.0) (2.3.2)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (3.0.2)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (0.8.0)\n",
      "Requirement already satisfied: thinc==7.4.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (7.4.1)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (4.47.0)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (49.2.0.post20200714)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (2.0.3)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: srsly<1.1.0,>=1.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: catalogue<1.1.0,>=0.0.7 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.0.0)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (2.24.0)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.1.3)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.19.2)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-craft-md==0.2.0) (0.4.1)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-craft-md==0.2.0) (2020.6.20)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-craft-md==0.2.0) (2.10)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-craft-md==0.2.0) (1.25.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-craft-md==0.2.0) (3.0.4)\n",
      "Building wheels for collected packages: en-ner-craft-md\n",
      "  Building wheel for en-ner-craft-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-ner-craft-md: filename=en_ner_craft_md-0.2.0-py3-none-any.whl size=82188130 sha256=1cb2f712261002da90bf2190f782f4c644aa18fd00dcc03b927796afed64f10d\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/18/0b/c7/fbe3fe04a87e0c38415317695cbd17d4ee98b856de4ca0aa9a\n",
      "Successfully built en-ner-craft-md\n",
      "Installing collected packages: en-ner-craft-md\n",
      "  Attempting uninstall: en-ner-craft-md\n",
      "    Found existing installation: en-ner-craft-md 0.2.5\n",
      "    Uninstalling en-ner-craft-md-0.2.5:\n",
      "      Successfully uninstalled en-ner-craft-md-0.2.5\n",
      "Successfully installed en-ner-craft-md-0.2.0\n",
      "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_jnlpba_md-0.2.0.tar.gz\n",
      "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_jnlpba_md-0.2.0.tar.gz (82.1 MB)\n",
      "\u001b[K     |████████████████████████████████| 82.1 MB 1.0 MB/s eta 0:00:011\n",
      "\u001b[?25hRequirement already satisfied: spacy>=2.1.3 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from en-ner-jnlpba-md==0.2.0) (2.3.2)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (2.0.3)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.19.2)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (3.0.2)\n",
      "Requirement already satisfied: setuptools in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (49.2.0.post20200714)\n",
      "Requirement already satisfied: catalogue<1.1.0,>=0.0.7 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.0.0)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (4.47.0)\n",
      "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.1.3)\n",
      "Requirement already satisfied: srsly<1.1.0,>=1.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: thinc==7.4.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (7.4.1)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.0.2)\n",
      "Requirement already satisfied: blis<0.5.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (0.4.1)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (2.24.0)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.4.0 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (0.8.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (2020.6.20)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (2.10)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (1.25.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /Users/sdeshpande/opt/anaconda3/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy>=2.1.3->en-ner-jnlpba-md==0.2.0) (3.0.4)\n",
      "Building wheels for collected packages: en-ner-jnlpba-md\n",
      "  Building wheel for en-ner-jnlpba-md (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for en-ner-jnlpba-md: filename=en_ner_jnlpba_md-0.2.0-py3-none-any.whl size=82195935 sha256=973a5eb39d9ef8ab75d058c6ac6d408191c49c78b409a9221102c182ba810849\n",
      "  Stored in directory: /Users/sdeshpande/Library/Caches/pip/wheels/92/ff/aa/45e0ad22eed381b99dbd1b13367df37d3a1b6d0266f088885d\n",
      "Successfully built en-ner-jnlpba-md\n",
      "Installing collected packages: en-ner-jnlpba-md\n",
      "  Attempting uninstall: en-ner-jnlpba-md\n",
      "    Found existing installation: en-ner-jnlpba-md 0.2.5\n",
      "    Uninstalling en-ner-jnlpba-md-0.2.5:\n",
      "      Successfully uninstalled en-ner-jnlpba-md-0.2.5\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully installed en-ner-jnlpba-md-0.2.0\r\n"
     ]
    }
   ],
   "source": [
    "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_craft_md-0.2.0.tar.gz    \n",
    "#biomedical NER model trained on CRAFT corpus\n",
    "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.0/en_ner_jnlpba_md-0.2.0.tar.gz     \n",
    "#biomedical NER model trained on JNLPBA corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "import en_ner_jnlpba_md\n",
    "import en_ner_craft_md"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">CORONAVIRUS RESEARCH: KEYS TO DIAGNOSIS, TREATMENT, AND PREVENTION OF SARS</br>Mark R. Denison, M.D.</br>For coronavirus investigators, the recognition of a new \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " as the cause of severe acute respiratory syndrome (SARS) was certainly remarkable, yet perhaps not surprising (Baric et al., 1995). The cadre of investigators who have worked with this intriguing family of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " over the past 30 years are familiar with many of the features of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " biology, pathogenesis, and disease that manifested so dramatically in the worldwide SARS epidemic. Advances in the biology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " have resulted in greater understanding of their capacity for adaptation to new environments, transspecies infection, and emergence of new diseases. New tools of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    molecular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " biology have led to increased understanding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intracellular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " replication and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " biology, and the advent in the past five years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    reverse genetic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " approaches to study coronaviruses has made it possible to begin to define the determinants of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " replication, transpecies adaptation, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " disease. This summary will discuss the basic life cycle and replication of the well-studied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " hepatitis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " (MHV), identifying the unique characteristics of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " biology and highlighting critical points where research has made significant advances, and which might represent targets for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    antivirals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " or vaccines. Areas where rapid progress has been made in SCoV research will be described. Finally, areas of need for research in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " replication, genetics, and pathogenesis will be summarized.</br>Coronavirus Life Cycle</br>The best studied model for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " replication and pathogenesis has been the group 2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    murine coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " hepatitis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", and much of what is known of the stages of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " life cycle has been determined in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    animals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " and in culture using this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ". Thus this discussion will focus on MHV with comparisons to SCoV and other coronaviruses. This is appropriate because bioinformatics analyses suggest that SCoV, while a distinct \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", has significant similarities in organization, putative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " functions, and replication to the group II coronaviruses, particularly within the replicase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gene\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " (Snijder et al., 2003). Excellent, detailed reviews of MHV and coronavirus replication are available elsewhere (Holmes and Lai, 1996; Lai and Cavanagh, 1997).</br>The coronavirus virion is an enveloped particle containing the spike (S), membrane (M), and envelope (E) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       ". In addition, some strains of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", but not SCoV, express a hemagglutinin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " (HE) that is also incorporated in the virion. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    genome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " is a linear, single-stranded \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " molecule of positive (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mRNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       ") polarity, and from 28 to 32 kb in length (Bonilla et al., 1994; Drosten et al., 2003; Lee et al., 1991). Within the virion, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    genome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    encapsidated\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " by multiple copies of the nucleocapsid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " (N), and has the conformation of a helical RNA/nucleocapsid structure. The S \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " has been a focus of pathogenesis studies in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " because it appears to be the critical determinant of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " tropism, species specificity, host selection, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " tropism, and disease (Navas and Weiss, 2003; Navas et al., 2001; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rao\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       " and Gallagher, 1998).</br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " replication is initiated by binding of the S \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " to specific receptors on the host \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell surface\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       ". For MHV, the primary receptor has been shown to be the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcino-embryonic antigen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " adhesion \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    molecule\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEACAM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       ") (Dveksler et al., 1991; 1996; Holmes and Lai, 1996; Yokomuri and Lai, 1992), and for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HCoV-229E\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", and other group 1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       ", the receptor is aminopeptidase N (Yeager et al., 1992). The precise mechanisms of entry and uncoating have yet to be defined, but likely occur by either fusion from without or viroplexis through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocytic vesicles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       ". For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    wildtype\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " MHV, entry and uncoating constitute a pH independent process that is probably direct fusion mediated by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fusion peptide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " in the S \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " (Gallagher et al., 1991). The understanding of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    region\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " of the S1 component of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " that binds to receptors was the basis for studies leading to the very recent and very rapid identification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin converting enzyme 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       ") as a receptor for SCoV (Li et al., 2003).</br>The next discrete stage in the life cycle is translation and proteolytic processing of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral replicase\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " from the input \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    genome RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       ", followed by formation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytoplasmic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " replication \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " in association with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cellular membranes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " (Denison et al., 1999; Gosert et al., 2002; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Shi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GGP</span>\n",
       "</mark>\n",
       " et al., 1999; van der Meer et al., 1999). Replication \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " are thought to be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " of all stages of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " transcription and replication, and possibly assembly of nascent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " nucleocapsids. Viral assembly occurs both temporally and physically distinct from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " replication \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " in the endoplasmic-reticulum-Golgi-intermediate compartment (ERGIC), a transitional zone between late \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Golgi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " (deVries et al., 1997; Klumperman et al., 1994; Krijnse-Locker et al., 1994; Rottier and Rose, 1987). Although the mechanisms by which replication products are delivered to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       " of assembly remain to be determined, it has been shown that subpopulations of replicase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span>\n",
       "</mark>\n",
       " and the structural nucleocapsid (N) translocate from replication \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sites of assembly and may\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " mediate the process in association with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cellular membrane/protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " trafficking pathways (Bost et al., 2000). Virus assembly in the ERGIC involves interactions of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    genome RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO</span>\n",
       "</mark>\n",
       ", N, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " (M), and the small \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " (E), resulting in budding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " into the lumen of ER/Golgi \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virosomes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " (Opstetten et al., 1995). Further maturation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus particles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " occurs during movement through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Golgi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       ", resulting in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virosomes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " filled with mature particles (Salamuera et al., 1999). Trafficking of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virosomes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell surface\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " has not been well characterized, but is presumed to occur via normal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vesicle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " maturation and exocytic processes. The outcome is the nonlytic release of the vast majority of mature \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    extracellular space\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       ". For MHV and several other coronaviruses that can directly fuse with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       ", there is a characteristic and rapidly detectable cytopathic effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell-cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span>\n",
       "</mark>\n",
       " fusion into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    multinucleated syncytia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       ". Production of infectious \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    virus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TAXON</span>\n",
       "</mark>\n",
       " continues even after the majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " are fused. Syncytia were recently reported as a readout of SCoV receptor expression and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span>\n",
       "</mark>\n",
       " infection (Li et al., 2003).</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "craft_entities = display_entities(en_ner_craft_md,sample_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entity</th>\n",
       "      <th>Label</th>\n",
       "      <th>Ner_model</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>proteins</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ACE 2</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>gene</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>viral replicase</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>multinucleated syncytia</td>\n",
       "      <td>CL</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>coronavirus</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>cell surface</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>intracellular</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>viral</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>protein</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>animals</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>murine coronavirus</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>mice</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Shi</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>sites</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>cellular membrane/protein</td>\n",
       "      <td>CL</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>virosomes</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>genome</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>viral cell</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>sites of assembly and may</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>human coronavirus</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>fusion peptide</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>mouse</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>region</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>virus particles</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>coronaviruses</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>cell-cell</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>ER</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>reverse genetic</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>membrane protein</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>angiotensin converting enzyme 2</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Virus</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>cellular membranes</td>\n",
       "      <td>CL</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>human</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>carcino-embryonic antigen</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>genome RNA</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>viral RNA</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>extracellular space</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>HCoV-229E</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>vesicle</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>RNA</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>complexes</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>endocytic vesicles</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>wildtype</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>encapsidated</td>\n",
       "      <td>SO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>antivirals</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>molecule</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>virions</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Golgi</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>mRNA</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Rao</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>cytoplasmic</td>\n",
       "      <td>GO</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>cells</td>\n",
       "      <td>CL</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>CEACAM</td>\n",
       "      <td>GGP</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>cell</td>\n",
       "      <td>CL</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>viruses</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>molecular</td>\n",
       "      <td>CHEBI</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>virus</td>\n",
       "      <td>TAXON</td>\n",
       "      <td>craft</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                             Entity  Label Ner_model\n",
       "0                          proteins  CHEBI     craft\n",
       "1                             ACE 2    GGP     craft\n",
       "2                              gene     SO     craft\n",
       "3                   viral replicase    GGP     craft\n",
       "4           multinucleated syncytia     CL     craft\n",
       "5                       coronavirus  TAXON     craft\n",
       "6                      cell surface     GO     craft\n",
       "7                     intracellular     GO     craft\n",
       "8                             viral  TAXON     craft\n",
       "9                           protein  CHEBI     craft\n",
       "10                          animals  TAXON     craft\n",
       "11               murine coronavirus  TAXON     craft\n",
       "12                             mice  TAXON     craft\n",
       "13                              Shi    GGP     craft\n",
       "14                            sites     SO     craft\n",
       "15        cellular membrane/protein     CL     craft\n",
       "16                        virosomes     GO     craft\n",
       "17                           genome     SO     craft\n",
       "18                       viral cell  TAXON     craft\n",
       "19        sites of assembly and may     GO     craft\n",
       "20                human coronavirus  TAXON     craft\n",
       "21                   fusion peptide     SO     craft\n",
       "22                            mouse  TAXON     craft\n",
       "23                           region     SO     craft\n",
       "24                  virus particles  TAXON     craft\n",
       "25                    coronaviruses  TAXON     craft\n",
       "26                        cell-cell     GO     craft\n",
       "27                               ER     GO     craft\n",
       "28                  reverse genetic     SO     craft\n",
       "29                 membrane protein     GO     craft\n",
       "30  angiotensin converting enzyme 2    GGP     craft\n",
       "31                            Virus  TAXON     craft\n",
       "32               cellular membranes     CL     craft\n",
       "33                            human  TAXON     craft\n",
       "34        carcino-embryonic antigen    GGP     craft\n",
       "35                       genome RNA     SO     craft\n",
       "36                        viral RNA  TAXON     craft\n",
       "37              extracellular space     GO     craft\n",
       "38                        HCoV-229E  TAXON     craft\n",
       "39                          vesicle     GO     craft\n",
       "40                              RNA     SO     craft\n",
       "41                        complexes     GO     craft\n",
       "42               endocytic vesicles     GO     craft\n",
       "43                         wildtype     SO     craft\n",
       "44                     encapsidated     SO     craft\n",
       "45                       antivirals  CHEBI     craft\n",
       "46                         molecule  CHEBI     craft\n",
       "47                          virions     GO     craft\n",
       "48                            Golgi     GO     craft\n",
       "49                             mRNA  CHEBI     craft\n",
       "50                              Rao    GGP     craft\n",
       "51                      cytoplasmic     GO     craft\n",
       "52                            cells     CL     craft\n",
       "53                           CEACAM    GGP     craft\n",
       "54                             cell     CL     craft\n",
       "55                          viruses  TAXON     craft\n",
       "56                        molecular  CHEBI     craft\n",
       "57                            virus  TAXON     craft"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "craft_entities_dataframe = pd.DataFrame(craft_entities[1],columns=['Entity','Label'])  #save returned values of entities and their labels in a pandas dataframe\n",
    "craft_entities_dataframe['Ner_model'] = 'craft' #include a column with constant value of NER model\n",
    "craft_entities_dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CORONAVIRUS RESEARCH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DNA</span>\n",
       "</mark>\n",
       ": KEYS TO DIAGNOSIS, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TREATMENT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DNA</span>\n",
       "</mark>\n",
       ", AND PREVENTION OF SARS</br>Mark R. Denison, M.D.</br>For coronavirus investigators, the recognition of a new coronavirus as the cause of severe acute respiratory syndrome (SARS) was certainly remarkable, yet perhaps not surprising (Baric et al., 1995). The cadre of investigators who have worked with this intriguing family of viruses over the past 30 years are familiar with many of the features of coronavirus biology, pathogenesis, and disease that manifested so dramatically in the worldwide SARS epidemic. Advances in the biology of coronaviruses have resulted in greater understanding of their capacity for adaptation to new environments, transspecies infection, and emergence of new diseases. New tools of cell and molecular biology have led to increased understanding of intracellular replication and viral cell biology, and the advent in the past five years of reverse genetic approaches to study coronaviruses has made it possible to begin to define the determinants of viral replication, transpecies adaptation, and human disease. This summary will discuss the basic life cycle and replication of the well-studied coronavirus, mouse hepatitis virus (MHV), identifying the unique characteristics of coronavirus biology and highlighting critical points where research has made significant advances, and which might represent targets for antivirals or vaccines. Areas where rapid progress has been made in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " research will be described. Finally, areas of need for research in coronavirus replication, genetics, and pathogenesis will be summarized.</br>Coronavirus Life Cycle</br>The best studied model for coronavirus replication and pathogenesis has been the group 2 murine coronavirus, mouse hepatitis virus, and much of what is known of the stages of the coronavirus life cycle has been determined in animals and in culture using this virus. Thus this discussion will focus on MHV with comparisons to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " and other coronaviruses. This is appropriate because bioinformatics analyses suggest that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ", while a distinct virus, has significant similarities in organization, putative protein functions, and replication to the group II coronaviruses, particularly within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replicase gene\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DNA</span>\n",
       "</mark>\n",
       " (Snijder et al., 2003). Excellent, detailed reviews of MHV and coronavirus replication are available elsewhere (Holmes and Lai, 1996; Lai and Cavanagh, 1997).</br>The coronavirus virion is an enveloped particle containing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike (S), membrane (M), and envelope (E) proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ". In addition, some strains of coronaviruses, but not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ", express a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemagglutinin protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ") that is also incorporated in the virion. The genome of coronaviruses is a linear, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    single-stranded RNA molecule\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    positive (mRNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">RNA</span>\n",
       "</mark>\n",
       ") polarity, and from 28 to 32 kb in length (Bonilla et al., 1994; Drosten et al., 2003; Lee et al., 1991). Within the virion, the genome is encapsidated by multiple copies of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleocapsid protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       "), and has the conformation of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    helical RNA/nucleocapsid structure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " has been a focus of pathogenesis studies in mice because it appears to be the critical determinant of cell tropism, species specificity, host selection, cell tropism, and disease (Navas and Weiss, 2003; Navas et al., 2001; Rao and Gallagher, 1998).</br>Virus replication is initiated by binding of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " to specific receptors on the host cell surface. For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MHV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    primary receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " has been shown to be the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcino-embryonic antigen–cell adhesion molecule\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEACAM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ") (Dveksler et al., 1991; 1996; Holmes and Lai, 1996; Yokomuri and Lai, 1992), and for the human coronavirus, HCoV-229E, and other group 1 coronaviruses, the receptor is aminopeptidase N (Yeager et al., 1992). The precise mechanisms of entry and uncoating have yet to be defined, but likely occur by either fusion from without or viroplexis through endocytic vesicles. For wildtype MHV, entry and uncoating constitute a pH independent process that is probably direct fusion mediated by a fusion peptide in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (Gallagher et al., 1991). The understanding of the region of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S1 component\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " of coronavirus that binds to receptors was the basis for studies leading to the very recent and very rapid identification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin converting enzyme 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ") as a receptor for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (Li et al., 2003).</br>The next discrete stage in the life cycle is translation and proteolytic processing of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral replicase proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " from the input genome RNA, followed by formation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytoplasmic replication complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " in association with cellular membranes (Denison et al., 1999; Gosert et al., 2002; Shi et al., 1999; van der Meer et al., 1999). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Replication complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " are thought to be sites of all stages of viral RNA transcription and replication, and possibly assembly of nascent viral nucleocapsids. Viral assembly occurs both temporally and physically distinct from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral replication complexes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " in the endoplasmic-reticulum-Golgi-intermediate compartment (ERGIC), a transitional zone between late \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " and Golgi (deVries et al., 1997; Klumperman et al., 1994; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Krijnse-Locker\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " et al., 1994; Rottier and Rose, 1987). Although the mechanisms by which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replication products\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " are delivered to sites of assembly remain to be determined, it has been shown that subpopulations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    replicase proteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    structural nucleocapsid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ") translocate from replication complexes to sites of assembly and may mediate the process in association with cellular membrane/protein trafficking pathways (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bost\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " et al., 2000). Virus assembly in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERGIC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DNA</span>\n",
       "</mark>\n",
       " involves interactions of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    genome RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">RNA</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    membrane protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (M), and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    small membrane protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    E\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       "), resulting in budding of virions into the lumen of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER/Golgi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " virosomes (Opstetten et al., 1995). Further maturation of virus particles occurs during movement through the Golgi, resulting in virosomes filled with mature particles (Salamuera et al., 1999). Trafficking of the virosomes to the cell surface has not been well characterized, but is presumed to occur via normal vesicle maturation and exocytic processes. The outcome is the nonlytic release of the vast majority of mature virions into the extracellular space. For MHV and several other coronaviruses that can directly fuse with cells, there is a characteristic and rapidly detectable cytopathic effect of cell-cell fusion into multinucleated syncytia. Production of infectious virus continues even after the majority of cells are fused. Syncytia were recently reported as a readout of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SCoV receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PROTEIN</span>\n",
       "</mark>\n",
       " expression and cell infection (Li et al., 2003).</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "jnlpba_entities = display_entities(en_ner_jnlpba_md,sample_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entity</th>\n",
       "      <th>Label</th>\n",
       "      <th>Ner_model</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>hemagglutinin protein</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>replicase gene</td>\n",
       "      <td>DNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>cytoplasmic replication complexes</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>HE</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>genome RNA</td>\n",
       "      <td>RNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>ER</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>single-stranded RNA molecule</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>structural nucleocapsid</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>viral replication complexes</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>angiotensin converting enzyme 2</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>membrane protein</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>SCoV</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>S protein</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>small membrane protein</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>nucleocapsid protein</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>spike (S), membrane (M), and envelope (E) prot...</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>replication products</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>positive (mRNA</td>\n",
       "      <td>RNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>ER/Golgi</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ERGIC</td>\n",
       "      <td>DNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Replication complexes</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>DNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>CORONAVIRUS RESEARCH</td>\n",
       "      <td>DNA</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Bost</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>SCoV receptor</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>primary receptor</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Krijnse-Locker</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>CEACAM</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>MHV</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>ACE 2</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>replicase proteins</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>helical RNA/nucleocapsid structure</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>viral replicase proteins</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>E</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>N</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>S1 component</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>carcino-embryonic antigen–cell adhesion molecule</td>\n",
       "      <td>PROTEIN</td>\n",
       "      <td>jnlpa</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               Entity    Label Ner_model\n",
       "0                               hemagglutinin protein  PROTEIN     jnlpa\n",
       "1                                      replicase gene      DNA     jnlpa\n",
       "2                   cytoplasmic replication complexes  PROTEIN     jnlpa\n",
       "3                                                  HE  PROTEIN     jnlpa\n",
       "4                                          genome RNA      RNA     jnlpa\n",
       "5                                                  ER  PROTEIN     jnlpa\n",
       "6                        single-stranded RNA molecule  PROTEIN     jnlpa\n",
       "7                             structural nucleocapsid  PROTEIN     jnlpa\n",
       "8                         viral replication complexes  PROTEIN     jnlpa\n",
       "9                     angiotensin converting enzyme 2  PROTEIN     jnlpa\n",
       "10                                   membrane protein  PROTEIN     jnlpa\n",
       "11                                               SCoV  PROTEIN     jnlpa\n",
       "12                                          S protein  PROTEIN     jnlpa\n",
       "13                             small membrane protein  PROTEIN     jnlpa\n",
       "14                               nucleocapsid protein  PROTEIN     jnlpa\n",
       "15  spike (S), membrane (M), and envelope (E) prot...  PROTEIN     jnlpa\n",
       "16                               replication products  PROTEIN     jnlpa\n",
       "17                                     positive (mRNA      RNA     jnlpa\n",
       "18                                           ER/Golgi  PROTEIN     jnlpa\n",
       "19                                              ERGIC      DNA     jnlpa\n",
       "20                              Replication complexes  PROTEIN     jnlpa\n",
       "21                                          TREATMENT      DNA     jnlpa\n",
       "22                               CORONAVIRUS RESEARCH      DNA     jnlpa\n",
       "23                                               Bost  PROTEIN     jnlpa\n",
       "24                                      SCoV receptor  PROTEIN     jnlpa\n",
       "25                                   primary receptor  PROTEIN     jnlpa\n",
       "26                                     Krijnse-Locker  PROTEIN     jnlpa\n",
       "27                                             CEACAM  PROTEIN     jnlpa\n",
       "28                                                MHV  PROTEIN     jnlpa\n",
       "29                                              ACE 2  PROTEIN     jnlpa\n",
       "30                                 replicase proteins  PROTEIN     jnlpa\n",
       "31                 helical RNA/nucleocapsid structure  PROTEIN     jnlpa\n",
       "32                           viral replicase proteins  PROTEIN     jnlpa\n",
       "33                                                  E  PROTEIN     jnlpa\n",
       "34                                                  N  PROTEIN     jnlpa\n",
       "35                                       S1 component  PROTEIN     jnlpa\n",
       "36   carcino-embryonic antigen–cell adhesion molecule  PROTEIN     jnlpa"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "jnlpa_entities_dataframe = pd.DataFrame(jnlpba_entities[1],columns=['Entity','Label']) #save returned values of entities and their labels in a pandas dataframe\n",
    "jnlpa_entities_dataframe['Ner_model'] = 'jnlpa' # include a column with constant value of NER model\n",
    "jnlpa_entities_dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 165 entries, 0 to 36\n",
      "Data columns (total 3 columns):\n",
      " #   Column     Non-Null Count  Dtype \n",
      "---  ------     --------------  ----- \n",
      " 0   Entity     165 non-null    object\n",
      " 1   Label      165 non-null    object\n",
      " 2   Ner_model  165 non-null    object\n",
      "dtypes: object(3)\n",
      "memory usage: 5.2+ KB\n"
     ]
    }
   ],
   "source": [
    "entities_and_label_from_4_NER_model_dataframe = pd.concat([bc5dr_entities_dataframe,bionlp13cg_entities_dataframe,craft_entities_dataframe,jnlpa_entities_dataframe])\n",
    "#Concatenate all pandas dataframe into one.\n",
    "entities_and_label_from_4_NER_model_dataframe.to_csv('entities_and_label_from_4_scispacy_NER_models.csv', index=False) #Save dataframe to csv\n",
    "entities_and_label_from_4_NER_model_dataframe.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entity</th>\n",
       "      <th>Label</th>\n",
       "      <th>Ner_model</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>acute respiratory syndrome</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>SARS</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>hepatitis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>infection</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Opstetten</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>bc5dr</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       Entity     Label Ner_model\n",
       "0  acute respiratory syndrome   DISEASE     bc5dr\n",
       "1                        SARS   DISEASE     bc5dr\n",
       "2                   hepatitis   DISEASE     bc5dr\n",
       "3                   infection   DISEASE     bc5dr\n",
       "4                   Opstetten  CHEMICAL     bc5dr"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "entities_and_label_from_4_NER_model_dataframe.head()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
